{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The goal of this neural network is to determine the usefulness of an article. \n",
    "\n",
    "A prompt is given to the Ollama LLM to classify an article as 0 (not useful) or 1 (useful)\n",
    "\n",
    "The neural network is then trained on a set of articles that the LLM has classified. \n",
    "\n",
    "After training, a new article can be inputed and given a score of 0 or 1 for it's usefulness with respect to the initial prompt."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "import numpy as np\n",
    "import os\n",
    "import pickle\n",
    "import copy\n",
    "import ollama\n",
    "\n",
    "\n",
    "import pandas as pd\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "import requests\n",
    "import xml.etree.ElementTree as ET\n",
    "import ollama\n",
    "from sklearn.model_selection import train_test_split\n",
    "\n",
    "\n",
    "\n",
    "import time\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Here's a breakdown of the libraries we're importing:\n",
    "\n",
    "`numpy` handles numerical computations for the neural network, \n",
    "`ollama` interfaces with the language model for embeddings and summaries, \n",
    "and `requests with xml.etree.ElementTree` enables PubMed API interactions to fetch article data. \n",
    "`pandas` organizes article metadata, `matplotlib` visualizes training metrics, and `sklearn` ensures proper train-test splitting. \n",
    "\n",
    "\n",
    "Additionally, `pickle` enables efficient data caching to store processed article embeddings and labels, reducing redundant computations. `time` is used for tracking processing duration, aiding performance optimization.\n",
    "\n",
    "These dependencies enable seamless data processing, model training, and result analysis, ensuring the project is robust and scalable.\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "\n",
    "#----------------\n",
    "# LAYER DENSE\n",
    "#----------------\n",
    "\n",
    "\n",
    "class Layer_Dense:\n",
    "    def __init__(self, n_inputs, n_neurons, weight_regularizer_l1=0, weight_regularizer_l2=0, bias_regularizer_l1=0, bias_regularizer_l2=0):\n",
    "        self.weights = .01 * np.random.randn(n_inputs, n_neurons)\n",
    "        self.biases = np.zeros((1, n_neurons))\n",
    "        self.weight_regularizer_l1 = weight_regularizer_l1\n",
    "        self.weight_regularizer_l2 = weight_regularizer_l2\n",
    "        self.bias_regularizer_l1 = bias_regularizer_l1\n",
    "        self.bias_regularizer_l2 = bias_regularizer_l2\n",
    "\n",
    "    def forward(self, inputs, training):\n",
    "        self.inputs = inputs\n",
    "        self.output = np.dot(inputs, self.weights) + self.biases\n",
    "        return self.output\n",
    "\n",
    "    def backward(self, dvalues):\n",
    "        self.dweights = np.dot(self.inputs.T, dvalues)\n",
    "        self.dbiases = np.sum(dvalues, axis=0, keepdims=True)\n",
    "        if self.weight_regularizer_l1 > 0:\n",
    "            dl1 = np.ones_like(self.weights)\n",
    "            dl1[self.weights < 0] = -1\n",
    "            self.dweights += self.weight_regularizer_l1 * dl1\n",
    "        if self.weight_regularizer_l2 > 0:\n",
    "            self.dweights += 2 * self.weight_regularizer_l2 * self.weights\n",
    "        if self.bias_regularizer_l1 > 0:\n",
    "            dl1 = np.ones_like(self.biases)\n",
    "            dl1[self.biases < 0] = -1\n",
    "            self.dbiases += self.bias_regularizer_l1 * dl1\n",
    "        if self.bias_regularizer_l2 > 0:\n",
    "            self.dbiases += 2 * self.bias_regularizer_l2 * self.biases\n",
    "        self.dinputs = np.dot(dvalues, self.weights.T)\n",
    "        return self.dinputs\n",
    "\n",
    "    def get_parameters(self):\n",
    "        return self.weights, self.biases\n",
    "\n",
    "    def set_parameters(self, weights, biases):\n",
    "        self.weights = weights\n",
    "        self.biases = biases\n",
    "\n",
    "class Layer_Dropout:\n",
    "    def __init__(self, rate):\n",
    "        self.rate = 1 - rate\n",
    "\n",
    "    def forward(self, inputs, training):\n",
    "        self.inputs = inputs\n",
    "        if not training:\n",
    "            self.output = inputs.copy()\n",
    "        else:\n",
    "            self.binary_mask = np.random.binomial(1, self.rate, size=inputs.shape) / self.rate\n",
    "            self.output = inputs * self.binary_mask\n",
    "        return self.output\n",
    "\n",
    "    def backward(self, dvalues):\n",
    "        self.dinputs = dvalues * self.binary_mask\n",
    "        return self.dinputs  # Added return\n",
    "\n",
    "class Layer_Input:\n",
    "    def forward(self, inputs, training):\n",
    "        self.output = inputs\n",
    "        return self.output\n",
    "\n",
    "#----------------\n",
    "# ACTIVATION FUNCTIONS\n",
    "#----------------\n",
    "\n",
    "\n",
    "class Activation_ReLU:\n",
    "    def forward(self, inputs, training):\n",
    "        self.inputs = inputs\n",
    "        self.output = np.maximum(0, inputs)\n",
    "        return self.output\n",
    "\n",
    "    def backward(self, dvalues):\n",
    "        self.dinputs = dvalues.copy()\n",
    "        self.dinputs[self.inputs <= 0] = 0\n",
    "        return self.dinputs\n",
    "\n",
    "    def predictions(self, outputs):\n",
    "        return outputs\n",
    "\n",
    "class Activation_Sigmoid:\n",
    "\n",
    "    def forward(self, inputs, training):\n",
    "        self.inputs = inputs\n",
    "        self.output = 1 / (1 + np.exp(-inputs))\n",
    "        return self.output\n",
    "\n",
    "    def backward(self, dvalues):\n",
    "        if self.output is None:\n",
    "            raise ValueError(\"Sigmoid backward: self.output is None; forward pass may not have been called correctly\")\n",
    "        self.dinputs = dvalues * (1 - self.output) * self.output\n",
    "        return self.dinputs\n",
    "\n",
    "    def predictions(self, outputs):\n",
    "        return (outputs > 0.5) * 1\n",
    "\n",
    "\n",
    "#----------------\n",
    "# OPTIMIZER\n",
    "#----------------\n",
    "\n",
    "\n",
    "class Optimizer_SGD:\n",
    "    def __init__(self, learning_rate=1., decay=0., momentum=0.):\n",
    "        self.learning_rate = learning_rate\n",
    "        self.current_learning_rate = learning_rate\n",
    "        self.decay = decay\n",
    "        self.iterations = 0\n",
    "        self.momentum = momentum\n",
    "\n",
    "    def pre_update_params(self):\n",
    "        if self.decay:\n",
    "            self.current_learning_rate = self.learning_rate * (1. / (1. + self.decay * self.iterations))\n",
    "\n",
    "    def update_params(self, layer):\n",
    "        if self.momentum:\n",
    "            if not hasattr(layer, 'weight_momentums'):\n",
    "                layer.weight_momentums = np.zeros_like(layer.weights)\n",
    "                layer.bias_momentums = np.zeros_like(layer.biases)\n",
    "            weight_updates = self.momentum * layer.weight_momentums - self.current_learning_rate * layer.dweights\n",
    "            layer.weight_momentums = weight_updates\n",
    "            bias_updates = self.momentum * layer.bias_momentums - self.current_learning_rate * layer.dbiases\n",
    "            layer.bias_momentums = bias_updates\n",
    "        else:\n",
    "            weight_updates = -self.current_learning_rate * layer.dweights\n",
    "            bias_updates = -self.current_learning_rate * layer.dbiases\n",
    "        layer.weights += weight_updates\n",
    "        layer.biases += bias_updates\n",
    "\n",
    "    def post_update_params(self):\n",
    "        self.iterations += 1\n",
    "\n",
    "\n",
    "#----------------\n",
    "# LOSS FUNCTIONS\n",
    "#----------------\n",
    "\n",
    "\n",
    "class Loss:\n",
    "    def regularization_loss(self):\n",
    "        regularization_loss = 0\n",
    "        for layer in self.trainable_layers:\n",
    "            if layer.weight_regularizer_l1 > 0:\n",
    "                regularization_loss += layer.weight_regularizer_l1 * np.sum(np.abs(layer.weights))\n",
    "            if layer.weight_regularizer_l2 > 0:\n",
    "                regularization_loss += layer.weight_regularizer_l2 * np.sum(layer.weights * layer.weights)\n",
    "            if layer.bias_regularizer_l1 > 0:\n",
    "                regularization_loss += layer.bias_regularizer_l1 * np.sum(np.abs(layer.biases))\n",
    "            if layer.bias_regularizer_l2 > 0:\n",
    "                regularization_loss += layer.bias_regularizer_l2 * np.sum(layer.biases * layer.biases)\n",
    "        return regularization_loss\n",
    "\n",
    "    def remember_trainable_layers(self, trainable_layers):\n",
    "        self.trainable_layers = trainable_layers\n",
    "\n",
    "    def calculate(self, output, y, *, include_regularization=False):\n",
    "        sample_losses = self.forward(output, y)\n",
    "        data_loss = np.mean(sample_losses)\n",
    "        self.accumulated_sum += np.sum(sample_losses)\n",
    "        self.accumulated_count += len(sample_losses)\n",
    "        if not include_regularization:\n",
    "            return data_loss\n",
    "        return data_loss, self.regularization_loss()\n",
    "\n",
    "    def calculate_accumulated(self, *, include_regularization=False):\n",
    "        data_loss = self.accumulated_sum / self.accumulated_count\n",
    "        if not include_regularization:\n",
    "            return data_loss\n",
    "        return data_loss, self.regularization_loss()\n",
    "\n",
    "    def new_pass(self):\n",
    "        self.accumulated_sum = 0\n",
    "        self.accumulated_count = 0\n",
    "\n",
    "\n",
    "\n",
    "class Loss_BinaryCrossEntropy(Loss):\n",
    "    def forward(self, y_pred, y_true):\n",
    "        y_pred_clipped = np.clip(y_pred, 1e-7, 1-1e-7)\n",
    "        if len(y_true.shape) == 1:\n",
    "            y_true = y_true[:, np.newaxis]\n",
    "        sample_losses = -(y_true * np.log(y_pred_clipped) + (1 - y_true) * np.log(1 - y_pred_clipped))\n",
    "        sample_losses = np.mean(sample_losses, axis=-1)\n",
    "        return sample_losses\n",
    "\n",
    "    def backward(self, dvalues, y_true):\n",
    "        samples = len(dvalues)\n",
    "        outputs = len(dvalues[0])\n",
    "        clipped_dvalues = np.clip(dvalues, 1e-7, 1-1e-7)\n",
    "        if len(y_true.shape) == 1:\n",
    "            y_true = y_true[:, np.newaxis]\n",
    "        self.dinputs = -(y_true / clipped_dvalues - (1 - y_true) / (1 - clipped_dvalues)) / outputs\n",
    "        self.dinputs = self.dinputs / samples\n",
    "        return self.dinputs\n",
    "\n",
    "\n",
    "#----------------\n",
    "# ACCURACY\n",
    "#----------------\n",
    "\n",
    "\n",
    "class Accuracy:\n",
    "    def calculate(self, predictions, y):\n",
    "        comparisons = self.compare(predictions, y)\n",
    "        accuracy = np.mean(comparisons)  # Fraction of correct predictions\n",
    "        self.accumulated_sum += np.sum(comparisons)  # Total correct\n",
    "        self.accumulated_count += len(comparisons)   # Total samples\n",
    "        return accuracy  # No need to cap if computed correctly\n",
    "\n",
    "    def calculate_accumulated(self):\n",
    "        if self.accumulated_count == 0:\n",
    "            return 0\n",
    "        accuracy = self.accumulated_sum / self.accumulated_count\n",
    "        return min(accuracy, 1.0)  # Cap here to catch any overflow\n",
    "\n",
    "    def new_pass(self):\n",
    "        self.accumulated_sum = 0\n",
    "        self.accumulated_count = 0\n",
    "\n",
    "class Accuracy_Binary(Accuracy):\n",
    "    def __init__(self):\n",
    "        self.new_pass()\n",
    "\n",
    "    def compare(self, predictions, y):\n",
    "        # Ensure both predictions and y are 1D\n",
    "        binary_predictions = (predictions > 0.5).flatten()  # Convert to 1D boolean\n",
    "        if len(y.shape) == 2:\n",
    "            y = y.flatten()  # Ensure y is 1D\n",
    "        if len(binary_predictions) != len(y):\n",
    "            raise ValueError(f\"Shape mismatch: predictions {binary_predictions.shape}, y {y.shape}\")\n",
    "        return binary_predictions == y  # 1D boolean array"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "These classes define the core components of the neural network architecture. \n",
    "Layer_Dense implements fully connected layers with support for L1/L2 regularization to prevent overfitting, crucial for handling high-dimensional article embeddings. \n",
    "\n",
    "Layer_Dropout introduces randomization during training to enhance model generalization, critical for small datasets. \n",
    "\n",
    "Layer_Input serves as the entry point for data, ensuring compatibility with the network. Together, they form a flexible, custom-built neural network tailored for binary classification of article usefulness.\n",
    "\n",
    "Activation functions introduce non-linearity and map outputs to desired ranges. \n",
    "Activation_ReLU accelerates training by applying a non-linear transformation to hidden layers, promoting sparse activations. \n",
    "\n",
    "Activation_Sigmoid is used in the output layer to produce probabilities between 0 and 1, ideal for binary classification of articles as useful or not useful. These functions ensure the model can learn complex patterns and deliver interpretable predictions.\n",
    "\n",
    "\n",
    "\n",
    "The Optimizer_SGD class implements stochastic gradient descent with momentum and learning rate decay, optimizing the neural network’s weights to minimize prediction errors. Momentum accelerates convergence by incorporating past gradients, while decay adjusts the learning rate to stabilize training. This optimizer ensures efficient and effective training, enabling the model to learn from article embeddings and improve classification accuracy.\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "Loss_BinaryCrossEntropy computes the loss for binary classification, guiding the model to minimize errors in predicting article usefulness. It includes regularization to penalize overly complex models, enhancing generalization. Accuracy_Binary measures the proportion of correct predictions, providing a clear metric to evaluate model performance. These components are essential for training and assessing the model’s ability to classify articles accurately.\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "#----------------\n",
    "# MODEL OBJECT\n",
    "#----------------\n",
    "\n",
    "class funny_guy:\n",
    "    def __init__(self):\n",
    "        self.layers = []\n",
    "\n",
    "    def add(self, layer):\n",
    "        self.layers.append(layer)\n",
    "\n",
    "    def set(self, *, loss, optimizer, accuracy):\n",
    "        if loss is not None:\n",
    "            self.loss = loss\n",
    "        if optimizer is not None:\n",
    "            self.optimizer = optimizer\n",
    "        if accuracy is not None:\n",
    "            self.accuracy = accuracy\n",
    "\n",
    "    def finalize(self):\n",
    "        self.input_layer = Layer_Input()\n",
    "        layer_count = len(self.layers)\n",
    "        self.trainable_layers = []\n",
    "        for i in range(layer_count):\n",
    "            if i == 0:\n",
    "                self.layers[i].prev = self.input_layer\n",
    "                self.layers[i].next = self.layers[i + 1]\n",
    "            elif i < layer_count - 1:\n",
    "                self.layers[i].prev = self.layers[i - 1]\n",
    "                self.layers[i].next = self.layers[i + 1]\n",
    "            else:\n",
    "                self.layers[i].prev = self.layers[i - 1]\n",
    "                self.layers[i].next = self.loss\n",
    "                self.output_layer_activation = self.layers[i]\n",
    "            if hasattr(self.layers[i], 'weights'):\n",
    "                self.trainable_layers.append(self.layers[i])\n",
    "        if self.loss is not None:\n",
    "            self.loss.remember_trainable_layers(self.trainable_layers)\n",
    "\n",
    "    def forward(self, X, training):\n",
    "        self.input_layer.forward(X, training)\n",
    "        output = self.input_layer.output\n",
    "        for layer in self.layers:\n",
    "            output = layer.forward(output, training)\n",
    "        return output\n",
    "\n",
    "    def backward(self, output, y):\n",
    "        dvalues = self.loss.backward(output, y)\n",
    "        for layer in reversed(self.layers):\n",
    "            dvalues = layer.backward(dvalues)\n",
    "        return dvalues\n",
    "\n",
    "    def train(self, X, y, *, epochs=1, batch_size=None, print_every=1, validation_data=None):\n",
    "        # Initialize history dictionary\n",
    "        self.history = {'train_loss': [], 'train_acc': [], 'val_loss': [], 'val_acc': []}\n",
    "\n",
    "        train_steps = 1\n",
    "        if batch_size is not None:\n",
    "            train_steps = len(X) // batch_size\n",
    "            if train_steps * batch_size < len(X):\n",
    "                train_steps += 1\n",
    "\n",
    "        for epoch in range(1, epochs + 1):\n",
    "            print(f'epoch: {epoch}')\n",
    "            self.loss.new_pass()\n",
    "            self.accuracy.new_pass()\n",
    "\n",
    "            for step in range(train_steps):\n",
    "                batch_X = X if batch_size is None else X[step * batch_size:(step + 1) * batch_size]\n",
    "                batch_y = y if batch_size is None else y[step * batch_size:(step + 1) * batch_size]\n",
    "\n",
    "                output = self.forward(batch_X, training=True)\n",
    "                data_loss, regularization_loss = self.loss.calculate(output, batch_y, include_regularization=True)\n",
    "                loss = data_loss + regularization_loss\n",
    "                predictions = self.output_layer_activation.predictions(output)\n",
    "                accuracy = self.accuracy.calculate(predictions, batch_y)\n",
    "\n",
    "                self.backward(output, batch_y)\n",
    "                self.optimizer.pre_update_params()\n",
    "                for layer in self.trainable_layers:\n",
    "                    self.optimizer.update_params(layer)\n",
    "                self.optimizer.post_update_params()\n",
    "\n",
    "                if not step % print_every or step == train_steps - 1:\n",
    "                    print(f'step: {step}, acc: {accuracy:.3f}, loss: {loss:.3f}, '\n",
    "                          f'(data_loss: {data_loss}, reg_loss: {regularization_loss:.3f}), '\n",
    "                          f'lr: {self.optimizer.current_learning_rate}')\n",
    "\n",
    "            # Store training metrics\n",
    "            epoch_data_loss, epoch_regularization_loss = self.loss.calculate_accumulated(include_regularization=True)\n",
    "            epoch_loss = epoch_data_loss + epoch_regularization_loss\n",
    "            epoch_accuracy = self.accuracy.calculate_accumulated()\n",
    "            self.history['train_loss'].append(epoch_loss)\n",
    "            self.history['train_acc'].append(epoch_accuracy)\n",
    "            print(f'training, acc: {epoch_accuracy:.3f}, loss: {epoch_loss:.3f}, '\n",
    "                  f'(data_loss: {epoch_data_loss}, reg_loss: {epoch_regularization_loss:.3f}), '\n",
    "                  f'lr: {self.optimizer.current_learning_rate}')\n",
    "\n",
    "            # Store validation metrics if provided\n",
    "            if validation_data is not None:\n",
    "                X_val, y_val = validation_data\n",
    "                val_loss, val_acc = self.evaluate(X_val, y_val, batch_size=batch_size)\n",
    "                self.history['val_loss'].append(val_loss)\n",
    "                self.history['val_acc'].append(val_acc)\n",
    "            else:\n",
    "                self.history['val_loss'].append(None)\n",
    "                self.history['val_acc'].append(None)\n",
    "\n",
    "        return self.history  # Return history for plotting\n",
    "\n",
    "    def evaluate(self, X_val, y_val, *, batch_size=None):\n",
    "        validation_steps = 1\n",
    "        if batch_size is not None:\n",
    "            validation_steps = len(X_val) // batch_size\n",
    "            if validation_steps * batch_size < len(X_val):\n",
    "                validation_steps += 1\n",
    "        self.loss.new_pass()\n",
    "        self.accuracy.new_pass()\n",
    "\n",
    "        for step in range(validation_steps):\n",
    "            batch_X = X_val if batch_size is None else X_val[step * batch_size:(step + 1) * batch_size]\n",
    "            batch_y = y_val if batch_size is None else y_val[step * batch_size:(step + 1) * batch_size]\n",
    "            output = self.forward(batch_X, training=False)\n",
    "            self.loss.calculate(output, batch_y)\n",
    "            predictions = self.output_layer_activation.predictions(output)\n",
    "            self.accuracy.calculate(predictions, batch_y)\n",
    "\n",
    "        validation_loss = self.loss.calculate_accumulated()\n",
    "        validation_accuracy = self.accuracy.calculate_accumulated()\n",
    "        print(f'validation, acc: {validation_accuracy:.3f}, loss: {validation_loss:.3f}')\n",
    "        print(f\"Val predictions: {predictions.flatten()}\")\n",
    "        return validation_loss, validation_accuracy  # Return metrics for history\n",
    "\n",
    "    def predict(self, X, *, batch_size=None):\n",
    "        prediction_steps = 1\n",
    "        if batch_size is not None:\n",
    "            prediction_steps = len(X) // batch_size\n",
    "            if prediction_steps * batch_size < len(X):\n",
    "                prediction_steps += 1\n",
    "        output = []\n",
    "        for step in range(prediction_steps):\n",
    "            batch_X = X if batch_size is None else X[step * batch_size:(step + 1) * batch_size]\n",
    "            batch_output = self.forward(batch_X, training=False)\n",
    "            output.append(batch_output)\n",
    "        return np.vstack(output)\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The funny_guy class orchestrates the neural network by managing layers, loss, optimizer, and accuracy. It supports forward and backward passes, training, evaluation, and prediction. \n",
    "\n",
    "The train method logs performance metrics and supports validation, enabling iterative improvements. \n",
    "\n",
    "This modular design allows easy experimentation with architectures and hyperparameters, making the model adaptable for classifying article usefulness.\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "#----------------\n",
    "# Pubmed Scraping \n",
    "#----------------\n",
    "\n",
    "\n",
    "def fetch_pubmed_ids(query, max_results=20):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    search_url = f\"{base_url}esearch.fcgi?db=pubmed&term={query}&retmax={max_results}&retmode=xml\"\n",
    "    response = requests.get(search_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch IDs: {response.status_code}\")\n",
    "    root = ET.fromstring(response.content)\n",
    "    return [id_elem.text for id_elem in root.findall(\".//Id\")]\n",
    "\n",
    "def fetch_pubmed_details(pmids):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    fetch_url = f\"{base_url}efetch.fcgi?db=pubmed&id={','.join(pmids)}&retmode=xml\"\n",
    "    response = requests.get(fetch_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch details: {response.status_code}\")\n",
    "    fetch_root = ET.fromstring(response.content)\n",
    "    articles = {}\n",
    "    fetched_pmids = set()\n",
    "    for article in fetch_root.findall(\".//PubmedArticle\"):\n",
    "        pmid = article.findtext(\".//PMID\")\n",
    "        title = article.findtext(\".//ArticleTitle\") or \"No title\"\n",
    "        abstract = article.findtext(\".//AbstractText\") or \"\"\n",
    "        articles[pmid] = {'title': title, 'abstract': abstract}\n",
    "        fetched_pmids.add(pmid)\n",
    "    missing = set(pmids) - fetched_pmids\n",
    "    if missing:\n",
    "        print(f\"Warning: Missing PMIDs in fetch: {missing}\")\n",
    "    return articles\n",
    "\n",
    "def get_ollama_embedding(text, model='nomic-embed-text'):\n",
    "    response = ollama.embeddings(model=model, prompt=text)\n",
    "    return np.array(response['embedding'])\n",
    "\n",
    "def get_ollama_summary(text, model='llama3'):\n",
    "    prompt = f\"Summarize the following article in 2-3 sentences:\\n\\n{text}\"\n",
    "    response = ollama.generate(model=model, prompt=prompt)\n",
    "    return response['response']\n",
    "\n",
    "def normalize_embeddings(X):\n",
    "    X_mean = np.mean(X, axis=0)\n",
    "    X_std = np.std(X, axis=0)\n",
    "    return (X - X_mean) / (X_std + 1e-8)  # Avoid division by zero\n",
    "\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading saved data from article_data.pkl\n",
      "epoch: 1\n",
      "step: 0, acc: 0.500, loss: 0.699, (data_loss: 0.6987388006625573, reg_loss: 0.000), lr: 0.005\n",
      "step: 2, acc: 0.500, loss: 0.694, (data_loss: 0.6943909165786921, reg_loss: 0.000), lr: 0.00499001996007984\n",
      "step: 3, acc: 0.750, loss: 0.691, (data_loss: 0.6913583640660993, reg_loss: 0.000), lr: 0.0049850448654037895\n",
      "training, acc: 0.438, loss: 0.696, (data_loss: 0.6956638943860933, reg_loss: 0.000), lr: 0.0049850448654037895\n",
      "validation, acc: 0.250, loss: 0.698\n",
      "Val predictions: [0 0 0 1]\n",
      "epoch: 2\n",
      "step: 0, acc: 0.500, loss: 0.692, (data_loss: 0.6922669095794045, reg_loss: 0.000), lr: 0.0049800796812749\n",
      "step: 2, acc: 0.750, loss: 0.687, (data_loss: 0.6874622072334874, reg_loss: 0.000), lr: 0.004970178926441352\n",
      "step: 3, acc: 0.750, loss: 0.690, (data_loss: 0.690380427700798, reg_loss: 0.000), lr: 0.00496524329692155\n",
      "training, acc: 0.500, loss: 0.692, (data_loss: 0.6915346271511962, reg_loss: 0.000), lr: 0.00496524329692155\n",
      "validation, acc: 0.000, loss: 0.698\n",
      "Val predictions: [0 1 0 1]\n",
      "epoch: 3\n",
      "step: 0, acc: 0.750, loss: 0.688, (data_loss: 0.6883752321464054, reg_loss: 0.000), lr: 0.004960317460317461\n",
      "step: 2, acc: 0.750, loss: 0.687, (data_loss: 0.6870345282950772, reg_loss: 0.000), lr: 0.0049504950495049506\n",
      "step: 3, acc: 0.750, loss: 0.691, (data_loss: 0.6911201161710898, reg_loss: 0.000), lr: 0.004945598417408507\n",
      "training, acc: 0.688, loss: 0.690, (data_loss: 0.6902433805203206, reg_loss: 0.000), lr: 0.004945598417408507\n",
      "validation, acc: 0.000, loss: 0.699\n",
      "Val predictions: [0 1 0 1]\n",
      "epoch: 4\n",
      "step: 0, acc: 1.000, loss: 0.684, (data_loss: 0.6839119548367949, reg_loss: 0.000), lr: 0.004940711462450593\n",
      "step: 2, acc: 0.750, loss: 0.683, (data_loss: 0.6825519532708528, reg_loss: 0.000), lr: 0.004930966469428008\n",
      "step: 3, acc: 0.750, loss: 0.691, (data_loss: 0.6910768258033989, reg_loss: 0.000), lr: 0.004926108374384237\n",
      "training, acc: 0.688, loss: 0.687, (data_loss: 0.6874188213856675, reg_loss: 0.000), lr: 0.004926108374384237\n",
      "validation, acc: 0.000, loss: 0.699\n",
      "Val predictions: [0 1 0 1]\n",
      "epoch: 5\n",
      "step: 0, acc: 1.000, loss: 0.680, (data_loss: 0.6802691272906186, reg_loss: 0.000), lr: 0.004921259842519685\n",
      "step: 2, acc: 0.750, loss: 0.679, (data_loss: 0.6789411035349008, reg_loss: 0.000), lr: 0.004911591355599214\n",
      "step: 3, acc: 0.500, loss: 0.694, (data_loss: 0.6936037841336834, reg_loss: 0.000), lr: 0.0049067713444553495\n",
      "training, acc: 0.750, loss: 0.686, (data_loss: 0.6858821604749954, reg_loss: 0.000), lr: 0.0049067713444553495\n",
      "validation, acc: 0.250, loss: 0.699\n",
      "Val predictions: [0 1 1 1]\n",
      "epoch: 6\n",
      "step: 0, acc: 1.000, loss: 0.679, (data_loss: 0.6786357796274929, reg_loss: 0.000), lr: 0.004901960784313725\n",
      "step: 2, acc: 0.750, loss: 0.678, (data_loss: 0.677761738139376, reg_loss: 0.000), lr: 0.004892367906066536\n",
      "step: 3, acc: 0.500, loss: 0.695, (data_loss: 0.695387325590567, reg_loss: 0.000), lr: 0.004887585532746824\n",
      "training, acc: 0.750, loss: 0.685, (data_loss: 0.684951999508313, reg_loss: 0.000), lr: 0.004887585532746824\n",
      "validation, acc: 0.500, loss: 0.699\n",
      "Val predictions: [1 1 1 1]\n",
      "epoch: 7\n",
      "step: 0, acc: 1.000, loss: 0.678, (data_loss: 0.6776414640141039, reg_loss: 0.000), lr: 0.0048828125\n",
      "step: 2, acc: 1.000, loss: 0.678, (data_loss: 0.6775607590316961, reg_loss: 0.000), lr: 0.004873294346978557\n",
      "step: 3, acc: 0.250, loss: 0.695, (data_loss: 0.6946069586924073, reg_loss: 0.000), lr: 0.004868549172346641\n",
      "training, acc: 0.750, loss: 0.684, (data_loss: 0.6840317891489978, reg_loss: 0.000), lr: 0.004868549172346641\n",
      "validation, acc: 0.500, loss: 0.699\n",
      "Val predictions: [1 1 1 1]\n",
      "epoch: 8\n",
      "step: 0, acc: 1.000, loss: 0.676, (data_loss: 0.676200506168342, reg_loss: 0.000), lr: 0.0048638132295719845\n",
      "step: 2, acc: 0.750, loss: 0.678, (data_loss: 0.6780612417494261, reg_loss: 0.000), lr: 0.004854368932038835\n",
      "step: 3, acc: 0.250, loss: 0.697, (data_loss: 0.6965645881208377, reg_loss: 0.000), lr: 0.004849660523763337\n",
      "training, acc: 0.688, loss: 0.684, (data_loss: 0.6840797911471941, reg_loss: 0.000), lr: 0.004849660523763337\n",
      "validation, acc: 0.500, loss: 0.699\n",
      "Val predictions: [1 1 1 1]\n",
      "epoch: 9\n",
      "step: 0, acc: 1.000, loss: 0.671, (data_loss: 0.6706924094821318, reg_loss: 0.000), lr: 0.0048449612403100775\n",
      "step: 2, acc: 1.000, loss: 0.672, (data_loss: 0.6720099912411446, reg_loss: 0.000), lr: 0.00483558994197292\n",
      "step: 3, acc: 0.500, loss: 0.696, (data_loss: 0.6959858795759122, reg_loss: 0.000), lr: 0.004830917874396136\n",
      "training, acc: 0.812, loss: 0.680, (data_loss: 0.6796125468723941, reg_loss: 0.000), lr: 0.004830917874396136\n",
      "validation, acc: 0.500, loss: 0.699\n",
      "Val predictions: [1 1 1 1]\n",
      "epoch: 10\n",
      "step: 0, acc: 1.000, loss: 0.664, (data_loss: 0.6642392410277045, reg_loss: 0.000), lr: 0.004826254826254826\n",
      "step: 2, acc: 0.750, loss: 0.671, (data_loss: 0.6714507802406603, reg_loss: 0.000), lr: 0.004816955684007708\n",
      "step: 3, acc: 0.000, loss: 0.699, (data_loss: 0.6991449803075731, reg_loss: 0.000), lr: 0.004812319538017325\n",
      "training, acc: 0.625, loss: 0.679, (data_loss: 0.6787921195804067, reg_loss: 0.000), lr: 0.004812319538017325\n",
      "validation, acc: 0.500, loss: 0.700\n",
      "Val predictions: [1 1 1 1]\n",
      "Predictions: [0.50580079 0.50961034 0.50436323 0.51321216]\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x500 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Manually Label Scraped Articles \n",
    "# 1 Useful, 0 Not useful\n",
    "\n",
    "\n",
    "\n",
    "def process_articles(pmids, articles_dict):\n",
    "    X, y, texts, summaries = [], [], [], []\n",
    "    valid_pmids = []\n",
    "    \n",
    "    # Step 1: Fetch and summarize articles\n",
    "    for pmid in pmids:\n",
    "        if pmid not in articles_dict:\n",
    "            print(f\"Warning: PMID {pmid} not found in articles_dict, skipping.\")\n",
    "            continue\n",
    "        article = articles_dict[pmid]\n",
    "        full_text = f\"{article['title']} {article['abstract']}\"\n",
    "        summary = get_ollama_summary(full_text)\n",
    "        embedding = get_ollama_embedding(summary)\n",
    "        X.append(embedding)\n",
    "        texts.append(full_text)\n",
    "        summaries.append(summary)\n",
    "        valid_pmids.append(pmid)\n",
    "    \n",
    "    X = np.array(X)\n",
    "    \n",
    "    # Step 2: Prompt user to label based on summaries\n",
    "    print(\"Label the following articles based on their summaries (1 = useful, 0 = not useful):\")\n",
    "    y = []\n",
    "    for i, pmid in enumerate(valid_pmids):\n",
    "        while True:\n",
    "            try:\n",
    "                label = int(input(f\"PMID {pmid}: {summaries[i][:250]}...\\nLabel (1/0): \"))\n",
    "                if label in [0, 1]:\n",
    "                    y.append(label)\n",
    "                    break\n",
    "                print(\"Please enter 0 or 1.\")\n",
    "            except ValueError:\n",
    "                print(\"Invalid input, please enter 0 or 1.\")\n",
    "    \n",
    "    # Step 3: Print full text and summary for reference\n",
    "    print(\"\\nProcessed articles:\")\n",
    "    for pmid, text, summary, label in zip(valid_pmids, texts, summaries, y):\n",
    "        print(f\"PMID {pmid}:\")\n",
    "        print(f\"Full Text: {text[:250]}...\")\n",
    "        print(f\"Summary: {summary}\")\n",
    "        print(f\"Label: {label}\\n\")\n",
    "    \n",
    "    return X, np.array(y)\n",
    "\n",
    "def create_article_data(query, max_results=20):\n",
    "    all_pmids = fetch_pubmed_ids(query, max_results)\n",
    "    train_pmids, test_pmids = train_test_split(all_pmids, test_size=0.2, random_state=42)\n",
    "    train_articles = fetch_pubmed_details(train_pmids)\n",
    "    test_articles = fetch_pubmed_details(test_pmids)\n",
    "    X_train, y_train = process_articles(train_pmids, train_articles)\n",
    "    X_test, y_test = process_articles(test_pmids, test_articles)\n",
    "    \n",
    "    # Normalize embeddings after creation\n",
    "    X_train = normalize_embeddings(X_train)\n",
    "    X_test = normalize_embeddings(X_test)\n",
    "    \n",
    "    assert not set(train_pmids) & set(test_pmids), \"Overlap detected!\"\n",
    "    return X_train, y_train, X_test, y_test\n",
    "\n",
    "# File to save/load data\n",
    "DATA_FILE = \"article_data.pkl\"\n",
    "\n",
    "def load_or_create_data(query, max_results):\n",
    "    \"\"\"Load saved data if it exists, otherwise create and save it.\"\"\"\n",
    "    if os.path.exists(DATA_FILE):\n",
    "        print(f\"Loading saved data from {DATA_FILE}\")\n",
    "        with open(DATA_FILE, 'rb') as f:\n",
    "            data = pickle.load(f)\n",
    "            return data['X_train'], data['y_train'], data['X_test'], data['y_test']\n",
    "    else:\n",
    "        print(f\"Creating new data for query: {query}\")\n",
    "        X_train, y_train, X_test, y_test = create_article_data(query, max_results)\n",
    "        data = {\n",
    "            'X_train': X_train,\n",
    "            'y_train': y_train,\n",
    "            'X_test': X_test,\n",
    "            'y_test': y_test\n",
    "        }\n",
    "        with open(DATA_FILE, 'wb') as f:\n",
    "            pickle.dump(data, f)\n",
    "        print(f\"Saved data to {DATA_FILE}\")\n",
    "        return X_train, y_train, X_test, y_test\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    query = \"machine learning cancer\"\n",
    "    max_results = 20\n",
    "\n",
    "    # Load or create data\n",
    "    X_train, y_train, X_test, y_test = load_or_create_data(query, max_results)\n",
    "\n",
    "    # Build and train model\n",
    "    model = funny_guy()\n",
    "    model.add(Layer_Dense(768, 64))\n",
    "    model.add(Activation_ReLU())\n",
    "    model.add(Layer_Dropout(.2))\n",
    "    model.add(Layer_Dense(64, 1))\n",
    "    model.add(Activation_Sigmoid())\n",
    "    model.set(\n",
    "        loss=Loss_BinaryCrossEntropy(),\n",
    "        optimizer=Optimizer_SGD(learning_rate=0.005, decay=1e-3),\n",
    "        accuracy=Accuracy_Binary()\n",
    "    )\n",
    "    model.finalize()\n",
    "\n",
    "    history = model.train(X_train, y_train, epochs=10, batch_size=4, print_every=2, validation_data=(X_test, y_test))\n",
    "\n",
    "    # Predict\n",
    "    predictions = model.predict(X_test[:5])\n",
    "    print(\"Predictions:\", predictions.flatten())\n",
    "\n",
    "    # Plotting\n",
    "    epochs_range = range(1, len(history['train_loss']) + 1)\n",
    "    plt.figure(figsize=(12, 5))\n",
    "    plt.subplot(1, 2, 1)\n",
    "    plt.plot(epochs_range, history['train_loss'], label='Training Loss')\n",
    "    plt.plot(epochs_range, history['val_loss'], label='Validation Loss')\n",
    "    plt.xlabel('Epochs')\n",
    "    plt.ylabel('Loss')\n",
    "    plt.title('Loss Over Epochs')\n",
    "    plt.legend()\n",
    "    plt.grid(True)\n",
    "    plt.subplot(1, 2, 2)\n",
    "    plt.plot(epochs_range, history['train_acc'], label='Training Accuracy')\n",
    "    plt.plot(epochs_range, history['val_acc'], label='Validation Accuracy')\n",
    "    plt.xlabel('Epochs')\n",
    "    plt.ylabel('Accuracy')\n",
    "    plt.title('Accuracy Over Epochs')\n",
    "    plt.legend()\n",
    "    plt.grid(True)\n",
    "    plt.tight_layout()\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "With only 20 articles, the model exhibited high validation loss (e.g., ~0.7) and accuracy barely above 50%, akin to random guessing. The small dataset limited the model’s ability to learn meaningful patterns from high-dimensional embeddings. Manual labeling of articles was also time-consuming, motivating automation with Llama3 for larger datasets to improve efficiency and scalability.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading saved data from article_data.pkl\n",
      "Train label balance: 0.5875\n",
      "Test label balance: 0.7\n",
      "epoch: 1\n",
      "step: 0, acc: 0.406, loss: 0.697, (data_loss: 0.6942626656846327, reg_loss: 0.002), lr: 0.008\n",
      "step: 2, acc: 0.312, loss: 0.697, (data_loss: 0.6944324738833376, reg_loss: 0.002), lr: 0.007999840003199938\n",
      "training, acc: 0.463, loss: 0.696, (data_loss: 0.6937730763287829, reg_loss: 0.002), lr: 0.007999840003199938\n",
      "validation, acc: 0.550, loss: 0.693\n",
      "Val predictions: [1 1 1 1 0 0 0 1 0 0 0 1 0 0 0 0 1 1 0 1]\n",
      "epoch: 2\n",
      "step: 0, acc: 0.438, loss: 0.696, (data_loss: 0.6938295363261124, reg_loss: 0.002), lr: 0.007999760007199784\n",
      "step: 2, acc: 0.688, loss: 0.694, (data_loss: 0.6910664389049616, reg_loss: 0.002), lr: 0.007999600019999\n",
      "training, acc: 0.600, loss: 0.695, (data_loss: 0.6924614628117378, reg_loss: 0.002), lr: 0.007999600019999\n",
      "validation, acc: 0.750, loss: 0.690\n",
      "Val predictions: [1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 3\n",
      "step: 0, acc: 0.625, loss: 0.695, (data_loss: 0.6921938945222116, reg_loss: 0.002), lr: 0.007999520028798272\n",
      "step: 2, acc: 0.750, loss: 0.691, (data_loss: 0.688746609585088, reg_loss: 0.002), lr: 0.007999360051195904\n",
      "training, acc: 0.662, loss: 0.693, (data_loss: 0.6904725988570247, reg_loss: 0.002), lr: 0.007999360051195904\n",
      "validation, acc: 0.700, loss: 0.687\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 4\n",
      "step: 0, acc: 0.562, loss: 0.693, (data_loss: 0.6910396989945738, reg_loss: 0.002), lr: 0.00799928006479417\n",
      "step: 2, acc: 0.750, loss: 0.688, (data_loss: 0.6851422464238278, reg_loss: 0.002), lr: 0.007999120096789353\n",
      "training, acc: 0.637, loss: 0.690, (data_loss: 0.6879424752450424, reg_loss: 0.002), lr: 0.007999120096789353\n",
      "validation, acc: 0.700, loss: 0.684\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 5\n",
      "step: 0, acc: 0.500, loss: 0.693, (data_loss: 0.690257237257371, reg_loss: 0.002), lr: 0.007999040115186179\n",
      "step: 2, acc: 0.688, loss: 0.682, (data_loss: 0.6793163973394692, reg_loss: 0.002), lr: 0.00799888015677805\n",
      "training, acc: 0.600, loss: 0.687, (data_loss: 0.6850206428936914, reg_loss: 0.002), lr: 0.00799888015677805\n",
      "validation, acc: 0.700, loss: 0.680\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 6\n",
      "step: 0, acc: 0.531, loss: 0.691, (data_loss: 0.688537812486817, reg_loss: 0.002), lr: 0.007998800179973004\n",
      "step: 2, acc: 0.688, loss: 0.679, (data_loss: 0.676551045052191, reg_loss: 0.002), lr: 0.007998640231160703\n",
      "training, acc: 0.613, loss: 0.685, (data_loss: 0.6823079587441961, reg_loss: 0.002), lr: 0.007998640231160703\n",
      "validation, acc: 0.700, loss: 0.676\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 7\n",
      "step: 0, acc: 0.562, loss: 0.688, (data_loss: 0.6857264140700883, reg_loss: 0.002), lr: 0.007998560259153352\n",
      "step: 2, acc: 0.688, loss: 0.673, (data_loss: 0.6709600383550394, reg_loss: 0.002), lr: 0.007998400319936013\n",
      "training, acc: 0.625, loss: 0.681, (data_loss: 0.6788334245811851, reg_loss: 0.002), lr: 0.007998400319936013\n",
      "validation, acc: 0.700, loss: 0.672\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 8\n",
      "step: 0, acc: 0.531, loss: 0.686, (data_loss: 0.6838527400428318, reg_loss: 0.002), lr: 0.007998320352725928\n",
      "step: 2, acc: 0.688, loss: 0.666, (data_loss: 0.6638056556218788, reg_loss: 0.002), lr: 0.007998160423102687\n",
      "training, acc: 0.625, loss: 0.677, (data_loss: 0.6741891144411835, reg_loss: 0.002), lr: 0.007998160423102687\n",
      "validation, acc: 0.700, loss: 0.667\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 9\n",
      "step: 0, acc: 0.562, loss: 0.682, (data_loss: 0.6795885672530569, reg_loss: 0.002), lr: 0.007998080460689434\n",
      "step: 2, acc: 0.688, loss: 0.658, (data_loss: 0.6550971973423881, reg_loss: 0.002), lr: 0.007997920540659429\n",
      "training, acc: 0.637, loss: 0.672, (data_loss: 0.6699215236108651, reg_loss: 0.002), lr: 0.007997920540659429\n",
      "validation, acc: 0.750, loss: 0.662\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 10\n",
      "step: 0, acc: 0.562, loss: 0.678, (data_loss: 0.6758597211893054, reg_loss: 0.002), lr: 0.007997840583042579\n",
      "step: 2, acc: 0.688, loss: 0.651, (data_loss: 0.649032074151032, reg_loss: 0.002), lr: 0.007997680672604946\n",
      "training, acc: 0.625, loss: 0.668, (data_loss: 0.6656524275791516, reg_loss: 0.002), lr: 0.007997680672604946\n",
      "validation, acc: 0.750, loss: 0.656\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 11\n",
      "step: 0, acc: 0.500, loss: 0.678, (data_loss: 0.6754013914623268, reg_loss: 0.002), lr: 0.007997600719784064\n",
      "step: 2, acc: 0.688, loss: 0.646, (data_loss: 0.643602766885585, reg_loss: 0.002), lr: 0.00799744081893794\n",
      "training, acc: 0.613, loss: 0.663, (data_loss: 0.6606863257756554, reg_loss: 0.002), lr: 0.00799744081893794\n",
      "validation, acc: 0.750, loss: 0.649\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 12\n",
      "step: 0, acc: 0.531, loss: 0.667, (data_loss: 0.6649794636855345, reg_loss: 0.002), lr: 0.0079973608709126\n",
      "step: 2, acc: 0.750, loss: 0.635, (data_loss: 0.6329169079802226, reg_loss: 0.002), lr: 0.007997200979657119\n",
      "training, acc: 0.650, loss: 0.653, (data_loss: 0.6500863911361442, reg_loss: 0.002), lr: 0.007997200979657119\n",
      "validation, acc: 0.750, loss: 0.641\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 13\n",
      "step: 0, acc: 0.656, loss: 0.663, (data_loss: 0.6607754018545323, reg_loss: 0.002), lr: 0.007997121036426887\n",
      "step: 2, acc: 0.750, loss: 0.620, (data_loss: 0.6173085305569044, reg_loss: 0.003), lr: 0.00799696115476119\n",
      "training, acc: 0.713, loss: 0.645, (data_loss: 0.642751880781046, reg_loss: 0.003), lr: 0.00799696115476119\n",
      "validation, acc: 0.750, loss: 0.633\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 14\n",
      "step: 0, acc: 0.750, loss: 0.650, (data_loss: 0.6478085213774445, reg_loss: 0.003), lr: 0.007996881216325634\n",
      "step: 2, acc: 0.875, loss: 0.603, (data_loss: 0.6002285115136645, reg_loss: 0.003), lr: 0.007996721344248859\n",
      "training, acc: 0.775, loss: 0.633, (data_loss: 0.6305981355049374, reg_loss: 0.003), lr: 0.007996721344248859\n",
      "validation, acc: 0.750, loss: 0.623\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1]\n",
      "epoch: 15\n",
      "step: 0, acc: 0.750, loss: 0.635, (data_loss: 0.6327170392807757, reg_loss: 0.003), lr: 0.007996641410607543\n",
      "step: 2, acc: 0.812, loss: 0.590, (data_loss: 0.5874288614709569, reg_loss: 0.003), lr: 0.007996481548118828\n",
      "training, acc: 0.800, loss: 0.617, (data_loss: 0.6148843250861455, reg_loss: 0.003), lr: 0.007996481548118828\n",
      "validation, acc: 0.750, loss: 0.611\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 0 1 1 1 0 0 1 1 1 1 1]\n",
      "epoch: 16\n",
      "step: 0, acc: 0.750, loss: 0.616, (data_loss: 0.6133681371042952, reg_loss: 0.003), lr: 0.007996401619271327\n",
      "step: 2, acc: 1.000, loss: 0.553, (data_loss: 0.5499704598890834, reg_loss: 0.003), lr: 0.007996241766369806\n",
      "training, acc: 0.812, loss: 0.599, (data_loss: 0.5965638776737733, reg_loss: 0.003), lr: 0.007996241766369806\n",
      "validation, acc: 0.850, loss: 0.598\n",
      "Val predictions: [1 1 1 1 1 1 1 1 0 0 1 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 17\n",
      "step: 0, acc: 0.781, loss: 0.600, (data_loss: 0.5974713900158641, reg_loss: 0.003), lr: 0.007996161842315688\n",
      "step: 2, acc: 1.000, loss: 0.519, (data_loss: 0.5168577221567676, reg_loss: 0.003), lr: 0.0079960019990005\n",
      "training, acc: 0.850, loss: 0.579, (data_loss: 0.5758817087919319, reg_loss: 0.003), lr: 0.0079960019990005\n",
      "validation, acc: 0.900, loss: 0.583\n",
      "Val predictions: [1 1 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 18\n",
      "step: 0, acc: 0.844, loss: 0.594, (data_loss: 0.5914296317853837, reg_loss: 0.003), lr: 0.007995922079739332\n",
      "step: 2, acc: 0.938, loss: 0.487, (data_loss: 0.4843061697055302, reg_loss: 0.003), lr: 0.007995762246009615\n",
      "training, acc: 0.850, loss: 0.563, (data_loss: 0.5604430818089265, reg_loss: 0.003), lr: 0.007995762246009615\n",
      "validation, acc: 0.900, loss: 0.566\n",
      "Val predictions: [1 1 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 19\n",
      "step: 0, acc: 0.906, loss: 0.556, (data_loss: 0.5533789553168715, reg_loss: 0.003), lr: 0.007995682331540969\n",
      "step: 2, acc: 1.000, loss: 0.444, (data_loss: 0.44079176288915245, reg_loss: 0.003), lr: 0.00799552250739586\n",
      "training, acc: 0.912, loss: 0.531, (data_loss: 0.5277511742387043, reg_loss: 0.003), lr: 0.00799552250739586\n",
      "validation, acc: 0.850, loss: 0.547\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 20\n",
      "step: 0, acc: 0.875, loss: 0.522, (data_loss: 0.5190506309062138, reg_loss: 0.003), lr: 0.007995442597719301\n",
      "step: 2, acc: 1.000, loss: 0.448, (data_loss: 0.44479765209850386, reg_loss: 0.003), lr: 0.007995282783157937\n",
      "training, acc: 0.912, loss: 0.505, (data_loss: 0.5022994980643785, reg_loss: 0.003), lr: 0.007995282783157937\n",
      "validation, acc: 0.850, loss: 0.528\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 21\n",
      "step: 0, acc: 0.906, loss: 0.476, (data_loss: 0.4728208147632537, reg_loss: 0.003), lr: 0.007995202878273036\n",
      "step: 2, acc: 1.000, loss: 0.385, (data_loss: 0.3820173306515213, reg_loss: 0.003), lr: 0.007995043073294556\n",
      "training, acc: 0.938, loss: 0.461, (data_loss: 0.45829253973702977, reg_loss: 0.003), lr: 0.007995043073294556\n",
      "validation, acc: 0.850, loss: 0.508\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 22\n",
      "step: 0, acc: 0.875, loss: 0.499, (data_loss: 0.49609652726854003, reg_loss: 0.003), lr: 0.007994963173200885\n",
      "step: 2, acc: 1.000, loss: 0.316, (data_loss: 0.31277126213948336, reg_loss: 0.003), lr: 0.007994803377804427\n",
      "training, acc: 0.912, loss: 0.446, (data_loss: 0.4430462328088957, reg_loss: 0.003), lr: 0.007994803377804427\n",
      "validation, acc: 0.850, loss: 0.489\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 23\n",
      "step: 0, acc: 0.938, loss: 0.426, (data_loss: 0.4226181669195876, reg_loss: 0.003), lr: 0.007994723482501548\n",
      "step: 2, acc: 1.000, loss: 0.293, (data_loss: 0.28959837467412497, reg_loss: 0.003), lr: 0.007994563696686253\n",
      "training, acc: 0.938, loss: 0.406, (data_loss: 0.4025031023059763, reg_loss: 0.003), lr: 0.007994563696686253\n",
      "validation, acc: 0.850, loss: 0.473\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 24\n",
      "step: 0, acc: 0.938, loss: 0.416, (data_loss: 0.4125508913850672, reg_loss: 0.003), lr: 0.007994483806173739\n",
      "step: 2, acc: 1.000, loss: 0.269, (data_loss: 0.2654163841316786, reg_loss: 0.003), lr: 0.007994324029938743\n",
      "training, acc: 0.950, loss: 0.385, (data_loss: 0.38183878004763566, reg_loss: 0.003), lr: 0.007994324029938743\n",
      "validation, acc: 0.850, loss: 0.458\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 25\n",
      "step: 0, acc: 0.969, loss: 0.374, (data_loss: 0.3705201267483359, reg_loss: 0.003), lr: 0.007994244144216164\n",
      "step: 2, acc: 1.000, loss: 0.236, (data_loss: 0.2330991292525676, reg_loss: 0.003), lr: 0.007994084377560606\n",
      "training, acc: 0.950, loss: 0.364, (data_loss: 0.3603956476247251, reg_loss: 0.003), lr: 0.007994084377560606\n",
      "validation, acc: 0.850, loss: 0.445\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 1 0 0 1 1 1 1 0]\n",
      "epoch: 26\n",
      "step: 0, acc: 0.938, loss: 0.355, (data_loss: 0.35121642563756084, reg_loss: 0.003), lr: 0.00799400449662753\n",
      "step: 2, acc: 1.000, loss: 0.240, (data_loss: 0.23665480376717885, reg_loss: 0.003), lr: 0.007993844739550546\n",
      "training, acc: 0.938, loss: 0.341, (data_loss: 0.33763722705577565, reg_loss: 0.003), lr: 0.007993844739550546\n",
      "validation, acc: 0.800, loss: 0.435\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 1 1 0]\n",
      "epoch: 27\n",
      "step: 0, acc: 0.938, loss: 0.319, (data_loss: 0.31537504848757425, reg_loss: 0.003), lr: 0.007993764863406543\n",
      "step: 2, acc: 1.000, loss: 0.173, (data_loss: 0.16920265754494068, reg_loss: 0.003), lr: 0.007993605115907274\n",
      "training, acc: 0.938, loss: 0.304, (data_loss: 0.3008553507656351, reg_loss: 0.003), lr: 0.007993605115907274\n",
      "validation, acc: 0.800, loss: 0.427\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 1 1 0]\n",
      "epoch: 28\n",
      "step: 0, acc: 0.938, loss: 0.325, (data_loss: 0.3218184975666746, reg_loss: 0.003), lr: 0.007993525244551913\n",
      "step: 2, acc: 1.000, loss: 0.136, (data_loss: 0.1321412438828209, reg_loss: 0.004), lr: 0.007993365506629496\n",
      "training, acc: 0.975, loss: 0.287, (data_loss: 0.28353632069754364, reg_loss: 0.004), lr: 0.007993365506629496\n",
      "validation, acc: 0.800, loss: 0.420\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 1 1 0]\n",
      "epoch: 29\n",
      "step: 0, acc: 0.969, loss: 0.304, (data_loss: 0.3004051326120438, reg_loss: 0.004), lr: 0.007993285640062348\n",
      "step: 2, acc: 1.000, loss: 0.173, (data_loss: 0.16922152021412118, reg_loss: 0.004), lr: 0.007993125911715923\n",
      "training, acc: 0.975, loss: 0.281, (data_loss: 0.27693625033203817, reg_loss: 0.004), lr: 0.007993125911715923\n",
      "validation, acc: 0.800, loss: 0.415\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 1 1 0]\n",
      "epoch: 30\n",
      "step: 0, acc: 0.969, loss: 0.291, (data_loss: 0.2869356663085638, reg_loss: 0.004), lr: 0.007993046049936557\n",
      "step: 2, acc: 1.000, loss: 0.142, (data_loss: 0.13854208733164897, reg_loss: 0.004), lr: 0.007992886331165263\n",
      "training, acc: 0.963, loss: 0.263, (data_loss: 0.2591917967851509, reg_loss: 0.004), lr: 0.007992886331165263\n",
      "validation, acc: 0.800, loss: 0.410\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 0 0 1 0 0 0 1 1 1 1 0]\n",
      "\n",
      "Test DataFrame with Predictions:\n",
      "    pmid  label  raw_prediction  binary_prediction\n",
      "40205450      1        0.847551                  1\n",
      "40211143      1        0.311087                  0\n",
      "40208029      1        0.675221                  1\n",
      "40214699      1        0.843660                  1\n",
      "40214892      1        0.877571                  1\n",
      "40216368      1        0.756671                  1\n",
      "40218289      1        0.926714                  1\n",
      "40206097      1        0.738299                  1\n",
      "40221553      0        0.219210                  0\n",
      "40223133      1        0.159694                  0\n",
      "40219965      0        0.217482                  0\n",
      "40217526      1        0.824417                  1\n",
      "40207200      1        0.481988                  0\n",
      "40216970      0        0.205713                  0\n",
      "40203502      0        0.029219                  0\n",
      "40222364      1        0.856943                  1\n",
      "40206813      0        0.699394                  1\n",
      "40206662      1        0.887219                  1\n",
      "40221445      1        0.752564                  1\n",
      "40217479      0        0.221981                  0\n",
      "Confusion Matrix:\n",
      " binary_prediction  0   1\n",
      "label                   \n",
      "0                  5   1\n",
      "1                  3  11\n"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x500 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# 100 articles, LLM labeling\n",
    "\n",
    "\n",
    "\n",
    "def fetch_pubmed_ids(query, max_results=60):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    search_url = f\"{base_url}esearch.fcgi?db=pubmed&term={query}&retmax={max_results}&retmode=xml\"\n",
    "    response = requests.get(search_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch IDs: {response.status_code}\")\n",
    "    root = ET.fromstring(response.content)\n",
    "    return [id_elem.text for id_elem in root.findall(\".//Id\")]\n",
    "\n",
    "def fetch_pubmed_details(pmids):\n",
    "    base_url = \"https://eutils.ncbi.nlm.nih.gov/entrez/eutils/\"\n",
    "    fetch_url = f\"{base_url}efetch.fcgi?db=pubmed&id={','.join(pmids)}&retmode=xml\"\n",
    "    response = requests.get(fetch_url)\n",
    "    if response.status_code != 200:\n",
    "        raise Exception(f\"Failed to fetch details: {response.status_code}\")\n",
    "    fetch_root = ET.fromstring(response.content)\n",
    "    articles = {}\n",
    "    fetched_pmids = set()\n",
    "    for article in fetch_root.findall(\".//PubmedArticle\"):\n",
    "        pmid = article.findtext(\".//PMID\")\n",
    "        title = article.findtext(\".//ArticleTitle\") or \"No title\"\n",
    "        abstract = article.findtext(\".//AbstractText\") or \"\"\n",
    "        articles[pmid] = {'title': title, 'abstract': abstract}\n",
    "        fetched_pmids.add(pmid)\n",
    "    missing = set(pmids) - fetched_pmids\n",
    "    if missing:\n",
    "        print(f\"Warning: Missing PMIDs in fetch: {missing}\")\n",
    "    return articles\n",
    "\n",
    "def get_ollama_embedding(text, model='nomic-embed-text'):\n",
    "    response = ollama.embeddings(model=model, prompt=text)\n",
    "    return np.array(response['embedding'])\n",
    "\n",
    "def get_ollama_summary(text, model='llama3'):\n",
    "    prompt = f\"Summarize the following article in 2-3 sentences:\\n\\n{text}\"\n",
    "    response = ollama.generate(model=model, prompt=prompt)\n",
    "    return response['response']\n",
    "\n",
    "\n",
    "def normalize_embeddings(X):\n",
    "    X_mean = np.mean(X, axis=0)\n",
    "    X_std = np.std(X, axis=0)\n",
    "    return (X - X_mean) / (X_std + 1e-8)  # Avoid division by zero\n",
    "\n",
    "\n",
    "def create_article_data(query, max_results=60):\n",
    "    all_pmids = fetch_pubmed_ids(query, max_results)\n",
    "    train_pmids, test_pmids = train_test_split(all_pmids, test_size=0.2, random_state=42)\n",
    "    train_articles = fetch_pubmed_details(train_pmids)\n",
    "    test_articles = fetch_pubmed_details(test_pmids)\n",
    "    \n",
    "    X_train, y_train, df_train = process_articles(train_pmids, train_articles, cache_file=\"train_embeddings.pkl\")\n",
    "    X_test, y_test, df_test = process_articles(test_pmids, test_articles, cache_file=\"test_embeddings.pkl\")\n",
    "    \n",
    "    X_train = normalize_embeddings(X_train)\n",
    "    X_test = normalize_embeddings(X_test)\n",
    "    \n",
    "    assert not set(train_pmids) & set(test_pmids), \"Overlap detected!\"\n",
    "    return X_train, y_train, X_test, y_test, df_train, df_test\n",
    "\n",
    "def process_articles(pmids, articles_dict, cache_file=\"embeddings.pkl\"):\n",
    "    # Check for cached data\n",
    "    if os.path.exists(cache_file):\n",
    "        with open(cache_file, 'rb') as f:\n",
    "            cached = pickle.load(f)\n",
    "            cached_pmids = set(cached['pmids'])\n",
    "            if set(pmids).issubset(cached_pmids):\n",
    "                print(\"Using cached embeddings and labels.\")\n",
    "                X, y = [], []\n",
    "                for pmid in pmids:\n",
    "                    idx = cached['pmids'].index(pmid)\n",
    "                    X.append(cached['X'][idx])\n",
    "                    y.append(cached['y'][idx])\n",
    "                return np.array(X), np.array(y), cached['df']  # Return cached DataFrame\n",
    "\n",
    "    X, y, texts, summaries = [], [], [], []\n",
    "    valid_pmids = []\n",
    "\n",
    "    # Prompt with your bias\n",
    "    prompt_template = \"\"\"\n",
    "You are an expert in machine learning and cancer research. Classify this summary as 'useful' (1) if it describes machine learning techniques (new or established) applied to cancer diagnosis or treatment with potential practical value (e.g., could improve outcomes or be implemented), or 'not useful' (0) if it’s purely theoretical, lacks ML, or is a review. Examples:\n",
    "- Useful (1): \"SVM model predicts breast cancer with 85% accuracy.\"\n",
    "- Useful (1): \"New CNN improves tumor detection in MRI scans.\"\n",
    "- Not Useful (0): \"Review of ML in oncology.\"\n",
    "Return only the label (0 or 1).\n",
    "Summary: {summary}\n",
    "\"\"\"\n",
    "\n",
    "    for pmid in pmids:\n",
    "        if pmid not in articles_dict:\n",
    "            print(f\"Warning: PMID {pmid} not found, skipping.\")\n",
    "            continue\n",
    "        article = articles_dict[pmid]\n",
    "        full_text = f\"{article['title']} {article['abstract']}\"\n",
    "        summary = get_ollama_summary(full_text)\n",
    "        embedding = get_ollama_embedding(summary)\n",
    "        X.append(embedding)\n",
    "        prompt = prompt_template.format(summary=summary)\n",
    "        response = ollama.generate(model='llama3', prompt=prompt)\n",
    "        label = int(response['response'].strip())\n",
    "\n",
    "        # Store data\n",
    "        valid_pmids.append(pmid)\n",
    "        texts.append(full_text)\n",
    "        summaries.append(summary)\n",
    "        y.append(label)\n",
    "\n",
    "    X = np.array(X)\n",
    "    y = np.array(y)\n",
    "\n",
    "    # Create DataFrame\n",
    "    df = pd.DataFrame({\n",
    "        'pmid': valid_pmids,\n",
    "        'full_text': texts,\n",
    "        'summary': summaries,\n",
    "        'label': y\n",
    "    })\n",
    "\n",
    "    # Print DataFrame instead of raw prints\n",
    "    print(\"\\nProcessed articles with LM labels:\")\n",
    "    print(df.to_string(index=False))  # Nicer formatting\n",
    "\n",
    "    # Cache results, including DataFrame\n",
    "    with open(cache_file, 'wb') as f:\n",
    "        pickle.dump({'pmids': valid_pmids, 'X': X, 'y': y, 'df': df}, f)\n",
    "\n",
    "    return X, y, df\n",
    "\n",
    "\n",
    "\n",
    "DATA_FILE = \"article_data.pkl\"\n",
    "\n",
    "def load_or_create_data(query, max_results):\n",
    "    if os.path.exists(DATA_FILE):\n",
    "        print(f\"Loading saved data from {DATA_FILE}\")\n",
    "        with open(DATA_FILE, 'rb') as f:\n",
    "            data = pickle.load(f)\n",
    "            return data['X_train'], data['y_train'], data['X_test'], data['y_test'], data['df_train'], data['df_test']\n",
    "    else:\n",
    "        print(f\"Creating new data for query: {query}\")\n",
    "        X_train, y_train, X_test, y_test, df_train, df_test = create_article_data(query, max_results)\n",
    "        data = {\n",
    "            'X_train': X_train, 'y_train': y_train,\n",
    "            'X_test': X_test, 'y_test': y_test,\n",
    "            'df_train': df_train, 'df_test': df_test\n",
    "        }\n",
    "        with open(DATA_FILE, 'wb') as f:\n",
    "            pickle.dump(data, f)\n",
    "        print(f\"Saved data to {DATA_FILE}\")\n",
    "        return X_train, y_train, X_test, y_test, df_train, df_test\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    query = \"machine learning cancer\"\n",
    "    max_results = 100\n",
    "\n",
    "    # Load or create data\n",
    "    X_train, y_train, X_test, y_test, df_train, df_test = load_or_create_data(query, max_results)\n",
    "\n",
    "    # Print label balance\n",
    "    print(\"Train label balance:\", np.mean(y_train))\n",
    "    print(\"Test label balance:\", np.mean(y_test))\n",
    "\n",
    "    # Build and train model\n",
    "    model = funny_guy()\n",
    "    model.add(Layer_Dense(768, 32, weight_regularizer_l2=1e-3))\n",
    "    model.add(Activation_ReLU())\n",
    "    model.add(Layer_Dropout(0.3))\n",
    "    model.add(Activation_ReLU())\n",
    "    model.add(Layer_Dense(32, 1, weight_regularizer_l2=1e-3))\n",
    "    model.add(Activation_Sigmoid())\n",
    "    model.set(\n",
    "        loss=Loss_BinaryCrossEntropy(),\n",
    "        optimizer=Optimizer_SGD(learning_rate=0.008, decay=1e-5, momentum=0.8),\n",
    "        accuracy=Accuracy_Binary())\n",
    "    model.finalize()\n",
    "    history = model.train(X_train, y_train, epochs=30, batch_size=32, print_every=2, validation_data=(X_test, y_test))\n",
    "\n",
    "    # Predictions and analysis\n",
    "    predictions = model.predict(X_test)\n",
    "    df_test['raw_prediction'] = predictions.flatten()\n",
    "    df_test['binary_prediction'] = (predictions > 0.5).astype(int)\n",
    "    print(\"\\nTest DataFrame with Predictions:\")\n",
    "    print(df_test[['pmid', 'label', 'raw_prediction', 'binary_prediction']].to_string(index=False))\n",
    "    print(\"Confusion Matrix:\\n\", pd.crosstab(df_test['label'], df_test['binary_prediction']))   \n",
    "    \n",
    "    # Plotting\n",
    "    epochs_range = range(1, len(history['train_loss']) + 1)\n",
    "    plt.figure(figsize=(12, 5))\n",
    "    plt.subplot(1, 2, 1)\n",
    "    plt.plot(epochs_range, history['train_loss'], label='Training Loss')\n",
    "    plt.plot(epochs_range, history['val_loss'], label='Validation Loss')\n",
    "    plt.xlabel('Epochs')\n",
    "    plt.ylabel('Loss')\n",
    "    plt.title('Loss Over Epochs')\n",
    "    plt.legend()\n",
    "    plt.grid(True)\n",
    "    plt.subplot(1, 2, 2)\n",
    "    plt.plot(epochs_range, history['train_acc'], label='Training Accuracy')\n",
    "    plt.plot(epochs_range, history['val_acc'], label='Validation Accuracy')\n",
    "    plt.xlabel('Epochs')\n",
    "    plt.ylabel('Accuracy')\n",
    "    plt.title('Accuracy Over Epochs')\n",
    "    plt.legend()\n",
    "    plt.grid(True)\n",
    "    plt.tight_layout()\n",
    "    plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Increasing the sample size to 100 helped tremendously, bringing accuracy way up and dropping loss across both training and validation. Will increasing the sample size further improve results? Below, the sample size is increased to 250. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Loading saved data from big_article_data.pkl\n",
      "Train label balance: 0.575\n",
      "Test label balance: 0.56\n"
     ]
    }
   ],
   "source": [
    "# SCRAP AND EMBED, store embeddings and data in a new file \"big_article_data\"\n",
    "\n",
    "\n",
    "def process_articles(pmids, articles_dict, cache_file):\n",
    "    # Check for cached data\n",
    "    if os.path.exists(cache_file):\n",
    "        with open(cache_file, 'rb') as f:\n",
    "            cached = pickle.load(f)\n",
    "            cached_pmids = set(cached['pmids'])\n",
    "            if set(pmids).issubset(cached_pmids):\n",
    "                print(f\"Using cached embeddings from {cache_file}\")\n",
    "                X, y = [], []\n",
    "                for pmid in pmids:\n",
    "                    idx = cached['pmids'].index(pmid)\n",
    "                    X.append(cached['X'][idx])\n",
    "                    y.append(cached['y'][idx])\n",
    "                return np.array(X), np.array(y), cached['df']\n",
    "\n",
    "    X, y, texts, summaries = [], [], [], []\n",
    "    valid_pmids = []\n",
    "\n",
    "    prompt_template = \"\"\"\n",
    "You are an expert in machine learning and cancer research. Classify this summary as 'useful' (1) if it describes machine learning techniques (new or established) applied to cancer diagnosis or treatment with potential practical value (e.g., could improve outcomes or be implemented), or 'not useful' (0) if it’s purely theoretical, lacks ML, or is a review. Examples:\n",
    "- Useful (1): \"SVM model predicts breast cancer with 85% accuracy.\"\n",
    "- Useful (1): \"New CNN improves tumor detection in MRI scans.\"\n",
    "- Not Useful (0): \"Review of ML in oncology.\"\n",
    "Return only the label (0 or 1).\n",
    "Summary: {summary}\n",
    "\"\"\"\n",
    "\n",
    "    for pmid in pmids:\n",
    "        if pmid not in articles_dict:\n",
    "            print(f\"Warning: PMID {pmid} not found, skipping.\")\n",
    "            continue\n",
    "        article = articles_dict[pmid]\n",
    "        full_text = f\"{article['title']} {article['abstract']}\"\n",
    "        summary = get_ollama_summary(full_text)\n",
    "        embedding = get_ollama_embedding(summary)\n",
    "        X.append(embedding)\n",
    "        prompt = prompt_template.format(summary=summary)\n",
    "        response = ollama.generate(model='llama3', prompt=prompt)\n",
    "        label = int(response['response'].strip())\n",
    "\n",
    "        valid_pmids.append(pmid)\n",
    "        texts.append(full_text)\n",
    "        summaries.append(summary)\n",
    "        y.append(label)\n",
    "\n",
    "    X = np.array(X)\n",
    "    y = np.array(y)\n",
    "\n",
    "    df = pd.DataFrame({\n",
    "        'pmid': valid_pmids,\n",
    "        'full_text': texts,\n",
    "        'summary': summaries,\n",
    "        'label': y\n",
    "    })\n",
    "\n",
    "    print(f\"\\nProcessed articles with LM labels ({cache_file}):\")\n",
    "    print(df.to_string(index=False))\n",
    "\n",
    "    with open(cache_file, 'wb') as f:\n",
    "        pickle.dump({'pmids': valid_pmids, 'X': X, 'y': y, 'df': df}, f)\n",
    "\n",
    "    return X, y, df\n",
    "\n",
    "def create_article_data(query, max_results=60):\n",
    "    all_pmids = fetch_pubmed_ids(query, max_results)\n",
    "    train_pmids, test_pmids = train_test_split(all_pmids, test_size=0.2, random_state=42)\n",
    "    train_articles = fetch_pubmed_details(train_pmids)\n",
    "    test_articles = fetch_pubmed_details(test_pmids)\n",
    "    \n",
    "    X_train, y_train, df_train = process_articles(train_pmids, train_articles, cache_file=TRAIN_CACHE)\n",
    "    X_test, y_test, df_test = process_articles(test_pmids, test_articles, cache_file=TEST_CACHE)\n",
    "    \n",
    "    X_train = normalize_embeddings(X_train)\n",
    "    X_test = normalize_embeddings(X_test)\n",
    "    \n",
    "    assert not set(train_pmids) & set(test_pmids), \"Overlap detected!\"\n",
    "    return X_train, y_train, X_test, y_test, df_train, df_test\n",
    "\n",
    "def load_or_create_data(query, max_results):\n",
    "    if os.path.exists(DATA_FILE):\n",
    "        print(f\"Loading saved data from {DATA_FILE}\")\n",
    "        with open(DATA_FILE, 'rb') as f:\n",
    "            data = pickle.load(f)\n",
    "            return data['X_train'], data['y_train'], data['X_test'], data['y_test'], data['df_train'], data['df_test']\n",
    "    else:\n",
    "        print(f\"Creating new data for query: {query}\")\n",
    "        X_train, y_train, X_test, y_test, df_train, df_test = create_article_data(query, max_results)\n",
    "        data = {\n",
    "            'X_train': X_train, 'y_train': y_train,\n",
    "            'X_test': X_test, 'y_test': y_test,\n",
    "            'df_train': df_train, 'df_test': df_test\n",
    "        }\n",
    "        with open(DATA_FILE, 'wb') as f:\n",
    "            pickle.dump(data, f)\n",
    "        print(f\"Saved data to {DATA_FILE}\")\n",
    "        return X_train, y_train, X_test, y_test, df_train, df_test\n",
    "\n",
    "# File paths for pickle files\n",
    "DATA_FILE = \"big_article_data.pkl\"\n",
    "TRAIN_CACHE = \"big_train_embeddings.pkl\"\n",
    "TEST_CACHE = \"big_test_embeddings.pkl\"\n",
    "\n",
    "\n",
    "# Main execution for scraping and embedding\n",
    "if __name__ == \"__main__\":\n",
    "    query = \"machine learning cancer\"\n",
    "    max_results = 250\n",
    "    X_train, y_train, X_test, y_test, df_train, df_test = load_or_create_data(query, max_results)\n",
    "    print(\"Train label balance:\", np.mean(y_train))\n",
    "    print(\"Test label balance:\", np.mean(y_test))\n",
    "\n",
    "\n",
    "\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "epoch: 1\n",
      "step: 0, acc: 0.600, loss: 0.693, (data_loss: 0.6922480570398122, reg_loss: 0.001), lr: 0.008\n",
      "step: 9, acc: 0.750, loss: 0.689, (data_loss: 0.687562530489725, reg_loss: 0.001), lr: 0.007998560259153352\n",
      "training, acc: 0.625, loss: 0.692, (data_loss: 0.6908376089194573, reg_loss: 0.001), lr: 0.007998560259153352\n",
      "validation, acc: 0.600, loss: 0.689\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 2\n",
      "step: 0, acc: 0.550, loss: 0.693, (data_loss: 0.6914899797695923, reg_loss: 0.001), lr: 0.007998400319936013\n",
      "step: 9, acc: 0.700, loss: 0.679, (data_loss: 0.6777912369958529, reg_loss: 0.001), lr: 0.00799696115476119\n",
      "training, acc: 0.660, loss: 0.684, (data_loss: 0.6831869778887727, reg_loss: 0.001), lr: 0.00799696115476119\n",
      "validation, acc: 0.600, loss: 0.682\n",
      "Val predictions: [1 1 1 1 1 1 1 1 1 1]\n",
      "epoch: 3\n",
      "step: 0, acc: 0.500, loss: 0.690, (data_loss: 0.6885532787832245, reg_loss: 0.001), lr: 0.007996801279488205\n",
      "step: 9, acc: 0.650, loss: 0.665, (data_loss: 0.6633788645724927, reg_loss: 0.001), lr: 0.007995362689640009\n",
      "training, acc: 0.670, loss: 0.672, (data_loss: 0.670975652616975, reg_loss: 0.001), lr: 0.007995362689640009\n",
      "validation, acc: 0.660, loss: 0.670\n",
      "Val predictions: [1 0 1 1 1 1 1 1 1 1]\n",
      "epoch: 4\n",
      "step: 0, acc: 0.550, loss: 0.675, (data_loss: 0.6741969441428901, reg_loss: 0.001), lr: 0.007995202878273036\n",
      "step: 9, acc: 0.700, loss: 0.644, (data_loss: 0.6423526967908303, reg_loss: 0.001), lr: 0.007993764863406543\n",
      "training, acc: 0.760, loss: 0.649, (data_loss: 0.6482000899225724, reg_loss: 0.001), lr: 0.007993764863406543\n",
      "validation, acc: 0.740, loss: 0.648\n",
      "Val predictions: [1 0 1 1 1 1 1 1 0 1]\n",
      "epoch: 5\n",
      "step: 0, acc: 0.750, loss: 0.652, (data_loss: 0.6502255773461171, reg_loss: 0.001), lr: 0.007993605115907274\n",
      "step: 9, acc: 0.800, loss: 0.586, (data_loss: 0.5849550959953711, reg_loss: 0.001), lr: 0.007992167675677836\n",
      "training, acc: 0.815, loss: 0.606, (data_loss: 0.6047742626218932, reg_loss: 0.001), lr: 0.007992167675677836\n",
      "validation, acc: 0.760, loss: 0.611\n",
      "Val predictions: [1 0 1 1 0 1 1 1 0 1]\n",
      "epoch: 6\n",
      "step: 0, acc: 0.900, loss: 0.582, (data_loss: 0.5811091039600076, reg_loss: 0.001), lr: 0.007992007992007994\n",
      "step: 9, acc: 0.750, loss: 0.547, (data_loss: 0.5456423194740458, reg_loss: 0.001), lr: 0.007990571126071237\n",
      "training, acc: 0.860, loss: 0.534, (data_loss: 0.5321162660614307, reg_loss: 0.001), lr: 0.007990571126071237\n",
      "validation, acc: 0.780, loss: 0.556\n",
      "Val predictions: [1 0 1 1 0 1 1 0 0 1]\n",
      "epoch: 7\n",
      "step: 0, acc: 0.850, loss: 0.527, (data_loss: 0.5256134111071767, reg_loss: 0.001), lr: 0.007990411506192568\n",
      "step: 9, acc: 0.850, loss: 0.459, (data_loss: 0.4571591054970693, reg_loss: 0.002), lr: 0.007988975214204398\n",
      "training, acc: 0.870, loss: 0.452, (data_loss: 0.4506022546093078, reg_loss: 0.002), lr: 0.007988975214204398\n",
      "validation, acc: 0.780, loss: 0.500\n",
      "Val predictions: [1 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 8\n",
      "step: 0, acc: 0.850, loss: 0.435, (data_loss: 0.4332073179308777, reg_loss: 0.002), lr: 0.007988815658078689\n",
      "step: 9, acc: 0.850, loss: 0.399, (data_loss: 0.3970684906842529, reg_loss: 0.002), lr: 0.007987379939695283\n",
      "training, acc: 0.885, loss: 0.374, (data_loss: 0.3718027820773698, reg_loss: 0.002), lr: 0.007987379939695283\n",
      "validation, acc: 0.820, loss: 0.454\n",
      "Val predictions: [0 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 9\n",
      "step: 0, acc: 0.850, loss: 0.371, (data_loss: 0.36917018857659845, reg_loss: 0.002), lr: 0.007987220447284345\n",
      "step: 9, acc: 0.850, loss: 0.317, (data_loss: 0.315527587281969, reg_loss: 0.002), lr: 0.007985785302162152\n",
      "training, acc: 0.910, loss: 0.311, (data_loss: 0.30898108956991405, reg_loss: 0.002), lr: 0.007985785302162152\n",
      "validation, acc: 0.840, loss: 0.418\n",
      "Val predictions: [0 0 1 0 0 1 0 0 0 1]\n",
      "epoch: 10\n",
      "step: 0, acc: 0.850, loss: 0.331, (data_loss: 0.3290078239023545, reg_loss: 0.002), lr: 0.00798562587342783\n",
      "step: 9, acc: 0.900, loss: 0.280, (data_loss: 0.2783449969914439, reg_loss: 0.002), lr: 0.007984191301223577\n",
      "training, acc: 0.910, loss: 0.264, (data_loss: 0.2623829597134924, reg_loss: 0.002), lr: 0.007984191301223577\n",
      "validation, acc: 0.840, loss: 0.390\n",
      "Val predictions: [0 0 1 0 0 1 0 0 0 1]\n",
      "epoch: 11\n",
      "step: 0, acc: 0.900, loss: 0.255, (data_loss: 0.25290678870925076, reg_loss: 0.002), lr: 0.007984031936127744\n",
      "step: 9, acc: 0.900, loss: 0.247, (data_loss: 0.2451091521970694, reg_loss: 0.002), lr: 0.007982597936498434\n",
      "training, acc: 0.935, loss: 0.222, (data_loss: 0.21964885916117402, reg_loss: 0.002), lr: 0.007982597936498434\n",
      "validation, acc: 0.860, loss: 0.366\n",
      "Val predictions: [0 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 12\n",
      "step: 0, acc: 0.900, loss: 0.226, (data_loss: 0.22371156393727323, reg_loss: 0.002), lr: 0.007982438635002994\n",
      "step: 9, acc: 1.000, loss: 0.198, (data_loss: 0.19571960397217228, reg_loss: 0.002), lr: 0.007981005207605897\n",
      "training, acc: 0.960, loss: 0.192, (data_loss: 0.1896186007695999, reg_loss: 0.002), lr: 0.007981005207605897\n",
      "validation, acc: 0.860, loss: 0.346\n",
      "Val predictions: [0 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 13\n",
      "step: 0, acc: 0.900, loss: 0.186, (data_loss: 0.18337974477655244, reg_loss: 0.002), lr: 0.007980845969672787\n",
      "step: 9, acc: 0.950, loss: 0.214, (data_loss: 0.21148678644834437, reg_loss: 0.002), lr: 0.007979413114165453\n",
      "training, acc: 0.960, loss: 0.167, (data_loss: 0.16413811808329512, reg_loss: 0.003), lr: 0.007979413114165453\n",
      "validation, acc: 0.860, loss: 0.328\n",
      "Val predictions: [0 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 14\n",
      "step: 0, acc: 0.900, loss: 0.175, (data_loss: 0.1727558143303771, reg_loss: 0.003), lr: 0.007979253939756634\n",
      "step: 9, acc: 0.950, loss: 0.180, (data_loss: 0.17697763250573667, reg_loss: 0.003), lr: 0.007977821655796885\n",
      "training, acc: 0.970, loss: 0.143, (data_loss: 0.14053752786229437, reg_loss: 0.003), lr: 0.007977821655796885\n",
      "validation, acc: 0.860, loss: 0.317\n",
      "Val predictions: [0 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 15\n",
      "step: 0, acc: 0.950, loss: 0.175, (data_loss: 0.1720002933337341, reg_loss: 0.003), lr: 0.007977662544874352\n",
      "step: 9, acc: 1.000, loss: 0.144, (data_loss: 0.14089472068241532, reg_loss: 0.003), lr: 0.007976230832120281\n",
      "training, acc: 0.985, loss: 0.131, (data_loss: 0.12824304416988427, reg_loss: 0.003), lr: 0.007976230832120281\n",
      "validation, acc: 0.880, loss: 0.307\n",
      "Val predictions: [0 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 16\n",
      "step: 0, acc: 0.950, loss: 0.155, (data_loss: 0.15272874999498925, reg_loss: 0.003), lr: 0.007976071784646063\n",
      "step: 9, acc: 1.000, loss: 0.155, (data_loss: 0.15261298633634618, reg_loss: 0.003), lr: 0.007974640642756036\n",
      "training, acc: 0.990, loss: 0.116, (data_loss: 0.1132216834189583, reg_loss: 0.003), lr: 0.007974640642756036\n",
      "validation, acc: 0.880, loss: 0.297\n",
      "Val predictions: [0 0 1 0 0 1 1 0 0 1]\n",
      "epoch: 17\n",
      "step: 0, acc: 0.950, loss: 0.141, (data_loss: 0.13777047952023633, reg_loss: 0.003), lr: 0.007974481658692184\n",
      "step: 9, acc: 1.000, loss: 0.100, (data_loss: 0.0973234770423245, reg_loss: 0.003), lr: 0.007973051087324842\n",
      "training, acc: 0.990, loss: 0.106, (data_loss: 0.10311781158269805, reg_loss: 0.003), lr: 0.007973051087324842\n",
      "validation, acc: 0.840, loss: 0.290\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 18\n",
      "step: 0, acc: 0.950, loss: 0.140, (data_loss: 0.13746943118604654, reg_loss: 0.003), lr: 0.007972892166633445\n",
      "step: 9, acc: 1.000, loss: 0.109, (data_loss: 0.10545998538971987, reg_loss: 0.003), lr: 0.007971462165447698\n",
      "training, acc: 0.990, loss: 0.096, (data_loss: 0.0933419476763915, reg_loss: 0.003), lr: 0.007971462165447698\n",
      "validation, acc: 0.840, loss: 0.285\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 19\n",
      "step: 0, acc: 1.000, loss: 0.093, (data_loss: 0.09006398859359778, reg_loss: 0.003), lr: 0.007971303308090873\n",
      "step: 9, acc: 1.000, loss: 0.102, (data_loss: 0.09855241244068132, reg_loss: 0.003), lr: 0.007969873876745902\n",
      "training, acc: 0.995, loss: 0.087, (data_loss: 0.08366242667984586, reg_loss: 0.003), lr: 0.007969873876745902\n",
      "validation, acc: 0.820, loss: 0.283\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 20\n",
      "step: 0, acc: 1.000, loss: 0.089, (data_loss: 0.08558995729881365, reg_loss: 0.003), lr: 0.007969715082685794\n",
      "step: 9, acc: 1.000, loss: 0.093, (data_loss: 0.08974368806121039, reg_loss: 0.003), lr: 0.007968286220841052\n",
      "training, acc: 0.995, loss: 0.082, (data_loss: 0.07902804744957467, reg_loss: 0.003), lr: 0.007968286220841052\n",
      "validation, acc: 0.820, loss: 0.280\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 21\n",
      "step: 0, acc: 1.000, loss: 0.094, (data_loss: 0.09022535153564373, reg_loss: 0.003), lr: 0.00796812749003984\n",
      "step: 9, acc: 1.000, loss: 0.090, (data_loss: 0.08644685041164817, reg_loss: 0.003), lr: 0.007966699197355055\n",
      "training, acc: 0.990, loss: 0.073, (data_loss: 0.06980333582846254, reg_loss: 0.003), lr: 0.007966699197355055\n",
      "validation, acc: 0.820, loss: 0.278\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 22\n",
      "step: 0, acc: 1.000, loss: 0.104, (data_loss: 0.10060420246359347, reg_loss: 0.003), lr: 0.007966540529774946\n",
      "step: 9, acc: 1.000, loss: 0.090, (data_loss: 0.08615851875135175, reg_loss: 0.003), lr: 0.007965112805910113\n",
      "training, acc: 0.995, loss: 0.072, (data_loss: 0.06851652079583884, reg_loss: 0.003), lr: 0.007965112805910113\n",
      "validation, acc: 0.820, loss: 0.275\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 23\n",
      "step: 0, acc: 1.000, loss: 0.077, (data_loss: 0.07370835685154435, reg_loss: 0.003), lr: 0.007964954201513342\n",
      "step: 9, acc: 1.000, loss: 0.066, (data_loss: 0.06295509548252999, reg_loss: 0.004), lr: 0.00796352704612873\n",
      "training, acc: 0.995, loss: 0.067, (data_loss: 0.06354454081675122, reg_loss: 0.004), lr: 0.00796352704612873\n",
      "validation, acc: 0.840, loss: 0.272\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 24\n",
      "step: 0, acc: 1.000, loss: 0.071, (data_loss: 0.06709037135732605, reg_loss: 0.004), lr: 0.007963368504877564\n",
      "step: 9, acc: 1.000, loss: 0.058, (data_loss: 0.05403843944472066, reg_loss: 0.004), lr: 0.00796194191763371\n",
      "training, acc: 1.000, loss: 0.059, (data_loss: 0.0549883183736732, reg_loss: 0.004), lr: 0.00796194191763371\n",
      "validation, acc: 0.840, loss: 0.271\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 25\n",
      "step: 0, acc: 1.000, loss: 0.053, (data_loss: 0.04922553528659786, reg_loss: 0.004), lr: 0.007961783439490446\n",
      "step: 9, acc: 1.000, loss: 0.069, (data_loss: 0.06542616290780523, reg_loss: 0.004), lr: 0.00796035742004816\n",
      "training, acc: 0.995, loss: 0.054, (data_loss: 0.049940624211616526, reg_loss: 0.004), lr: 0.00796035742004816\n",
      "validation, acc: 0.840, loss: 0.270\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 26\n",
      "step: 0, acc: 1.000, loss: 0.061, (data_loss: 0.05720770564019858, reg_loss: 0.004), lr: 0.007960199004975126\n",
      "step: 9, acc: 1.000, loss: 0.035, (data_loss: 0.03094505144601949, reg_loss: 0.004), lr: 0.007958773552995483\n",
      "training, acc: 1.000, loss: 0.042, (data_loss: 0.03804612530675358, reg_loss: 0.004), lr: 0.007958773552995483\n",
      "validation, acc: 0.840, loss: 0.269\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 27\n",
      "step: 0, acc: 1.000, loss: 0.059, (data_loss: 0.05482310456690833, reg_loss: 0.004), lr: 0.007958615200955033\n",
      "step: 9, acc: 1.000, loss: 0.048, (data_loss: 0.04369739643524171, reg_loss: 0.004), lr: 0.007957190316099386\n",
      "training, acc: 0.995, loss: 0.045, (data_loss: 0.04123965201634048, reg_loss: 0.004), lr: 0.007957190316099386\n",
      "validation, acc: 0.840, loss: 0.269\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "epoch: 28\n",
      "step: 0, acc: 1.000, loss: 0.050, (data_loss: 0.0460033620469671, reg_loss: 0.004), lr: 0.007957032027053909\n",
      "step: 9, acc: 1.000, loss: 0.036, (data_loss: 0.03188963291469788, reg_loss: 0.004), lr: 0.00795560770898387\n",
      "training, acc: 0.995, loss: 0.047, (data_loss: 0.04355422498366469, reg_loss: 0.004), lr: 0.00795560770898387\n",
      "validation, acc: 0.840, loss: 0.267\n",
      "Val predictions: [0 0 1 0 0 1 1 0 1 1]\n",
      "\n",
      "Test DataFrame with Predictions:\n",
      "    pmid                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              full_text                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   summary  label  raw_prediction  binary_prediction\n",
      "40343491                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis. The aim of this study is to better characterize the clinical characteristics and outcomes of patients diagnosed with Immune checkpoint Inhibitor (ICI) pneumonitis and propose predictive models.                                                                                                                                                                                                                                                            Here is a summary of the article in 2-3 sentences:\\n\\nThe study aims to understand the clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis. The researchers sought to characterize the disease by analyzing patient demographics, symptoms, and treatment outcomes. They also aimed to develop predictive models to identify factors that may indicate a higher risk of developing ICI pneumonitis.      0        0.002994                  0\n",
      "40370448                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Corrigendum: Harnessing single-cell and multi-omics insights: STING pathway-based predictive signature for immunotherapy response in lung adenocarcinoma. [This corrects the article DOI: 10.3389/fimmu.2025.1575084.].                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 There is no content to summarize as the article appears to be a corrigendum, which is a correction or update to an existing article. It does not contain new information and only references a previous publication with a corrected DOI.      0        0.000007                  0\n",
      "40352269                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Development of an immune-related gene signature applying Ridge method for improving immunotherapy responses and clinical outcomes in lung adenocarcinoma. Lung adenocarcinoma (LUAD) is a major cause of cancer mortality. Considering the critical role of tumor infiltrating lymphocytes in effective immunotherapy, this study was designed to screen molecular markers related to tumor infiltrating cells in LUAD, aiming to improve immunotherapy response during LUAD therapy.                                                                                                                                                                                                                                                                          Here is a summary of the article in 2-3 sentences:\\n\\nThe study aimed to identify molecular markers that predict immune responses and clinical outcomes in patients with lung adenocarcinoma (LUAD). The researchers used the Ridge method to develop an immune-related gene signature, which can help improve immunotherapy responses and outcomes in LUAD. This signature may be useful for identifying patients who are most likely to benefit from immunotherapy treatments.      1        0.468875                  0\n",
      "40358526                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Nonparametric IPSS: Fast, flexible feature selection with false discovery control. Feature selection is a critical task in machine learning and statistics. However, existing feature selection methods either (i) rely on parametric methods such as linear or generalized linear models, (ii) lack theoretical false discovery control, or (iii) identify few true positives.                                                                                                                                                                                                                                                                            Here is a summary of the article in 2-3 sentences:\\n\\nThe article discusses the importance of feature selection in machine learning and statistics, where existing methods often rely on parametric approaches, lack theoretical false discovery control, or only identify a few true positives. Nonparametric IPSS (NIPSS) is introduced as a novel approach that addresses these limitations by offering fast, flexible feature selection with controlled false discoveries.      0        0.108177                  0\n",
      "40348669                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Exploring morphological heterogeneity of circulating tumor cells: machine learning-based approach for cell identification and prognostic implications.                                                                                                                                                                                                                                             The article discusses a machine learning-based approach to identify and characterize circulating tumor cells (CTCs) based on their morphological features. This method uses computer vision and machine learning algorithms to analyze images of CTCs and predict their morphology, which can be used to inform patient prognosis. The study shows that the morphological heterogeneity of CTCs is associated with poorer patient outcomes, highlighting the potential clinical applications of this approach.      1        0.999611                  1\n",
      "40335510                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Oral microbiome-derived biomarkers for non-invasive diagnosis of head and neck squamous cell carcinoma. Mounting evidence suggests that sustained microbial dysbiosis is associated with the development of multiple cancers, while the species-level bacterial taxa and metabolic dysfunction of oral microbiome in patients with head and neck squamous cell carcinoma (HNSCC) remains unclear. In this cross-sectional study, comprehensive metagenomic and 16S rRNA amplicon sequencing analyses of oral swab samples from 172 patients were performed. Unsupervised clustering algorithms of relative microbial abundance profiles revealed three distinctive microbiome clusters. Based on the metagenomic and 16S rRNA amplicon sequencing data, machine learning-based methods were used to construct the HNSCC diagnostic classifier, which exhibited high area under the curve values of 0.78-0.89. Our study provided the first exhaustive metagenomic and 16S rRNA amplicon sequencing analyses to date, revealing that microbial-metabolic dysbiosis is a potential risk factor for HNSCC progression and therefore providing a robust theoretical basis for potential diagnostic and therapeutic strategies for HNSCC patients.                                                                                                 Here is a summary of the article in 3 sentences:\\n\\nResearchers analyzed oral swab samples from 172 patients to investigate the relationship between the oral microbiome and head and neck squamous cell carcinoma (HNSCC). The study used machine learning methods to identify three distinct microbial clusters and develop a diagnostic classifier that showed high accuracy in distinguishing HNSCC patients from healthy individuals. The findings suggest that microbial-metabolic dysbiosis is a potential risk factor for HNSCC progression, providing a basis for developing non-invasive diagnostic and therapeutic strategies for the disease.      1        0.788992                  1\n",
      "40330476                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       METTL1-driven nucleotide metabolism reprograms the immune microenvironment in hepatocellular carcinoma: a multi-omics approach for prognostic biomarker discovery. Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related mortality worldwide, partly due to an incomplete understanding of the metabolic and immune dysregulation driving its progression. Here, we uncover a novel role of METTL1 in driving nucleotide metabolism reprogramming, which significantly modulates the tumor immune microenvironment.                                                                                                                                                                                                                                                                                                                              Here is a summary of the article in 2-3 sentences:\\n\\nResearchers have discovered that the protein METTL1 plays a key role in reprogramming nucleotide metabolism in hepatocellular carcinoma (HCC), leading to significant changes in the tumor's immune microenvironment. This finding may hold promise for identifying new prognostic biomarkers for HCC, which is a leading cause of cancer-related mortality worldwide.      0        0.179626                  0\n",
      "40335073                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              A Digital Score Based on Circulating-Tumor-Cells-Derived mRNA Quantification and Machine Learning for Early Colorectal Cancer Detection. Circulating tumor cells (CTCs) serve as valuable biomarkers in tumor circulation, carrying essential primary tumor information. The purification of CTCs from peripheral blood samples and the analysis of their characteristic molecules enable the detection of tumors at an early stage. The noninvasive, continuous, real-time dynamic monitoring provides a promising solution for the timely diagnosis of colorectal cancer (CRC). In this study, we developed a minimally invasive method for CRC early detection to enable accurate screening in a friendly manner for individuals who generally require colonoscopy. The dual-antibody (i.e., anti-EpCAM and anti-EGFR) modified antifouling hydrogel-coated magnetic nanoparticles (pSBMA-MNPs) were prepared for efficient and specific CTC purification. Then, the quantification of 6 RNA transcripts in purified CRC CTCs was performed via droplet digital PCR (ddPCR), and a CRC score was calculated using an extreme gradient boosting model to distinguish CRC from colon polyps and adenomas. A pilot study was conducted to evaluate the clinical potential of the CRC CTC RNA assay in a training cohort (                                                                                                                                                                                                                                                                                         Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a non-invasive test for early detection of colorectal cancer (CRC) using circulating tumor cells (CTCs) and machine learning. The test uses magnetic nanoparticles to purify CTCs from blood samples, followed by digital PCR analysis of six RNA transcripts. A pilot study showed the potential of this CRC score-based assay in distinguishing CRC from colon polyps and adenomas.      1        0.964138                  1\n",
      "40369609                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Machine learning prediction model of prolonged delay to loop ileostomy closure after rectal cancer surgery: a retrospective study. Delayed closure of a temporary ileostomy in patients with rectal cancer may cause psychological, physiological, and socioeconomic burdens to patients.                                                                                                                                                                                                                                                                                                                                                                                                   Here is a summary of the article in 2-3 sentences:\\n\\nA machine learning prediction model was developed to identify factors associated with prolonged delay in closing a loop ileostomy after rectal cancer surgery. The study aimed to reduce the physical, emotional, and financial burdens caused by delayed closure on patients with rectal cancer.      0        0.471184                  0\n",
      "40350060                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Computationally enabled polychromatic polarized imaging enables mapping of matrix architectures that promote pancreatic ductal adenocarcinoma dissemination. Pancreatic ductal adenocarcinoma (PDA) is an extremely metastatic and lethal disease. In PDA, extracellular matrix (ECM) architectures known as Tumor-Associated Collagen Signatures (TACS) regulate invasion and metastatic spread in both early dissemination and in late-stage disease. As such, TACS has been suggested as a biomarker to aid in pathologic assessment. However, despite its significance, approaches to quantitatively capture these ECM patterns currently require advanced optical systems with signaling processing analysis. Here we present an expansion of polychromatic polarized microscopy (PPM) with inherent angular information coupled to machine learning and computational pixel-wise analysis of TACS. Using this platform, we are able to accurately capture TACS architectures in H&E stained histology sections directly through PPM contrast. Moreover, PPM facilitated identification of transitions to dissemination architectures, i.e., transitions from sequestration through expansion to dissemination from both PanINs and throughout PDA. Lastly, PPM evaluation of architectures in liver metastases, the most common metastatic site for PDA, demonstrates TACS-mediated focal and local invasion as well as identification of unique patterns anchoring aligned fibers into normal-adjacent tumor, suggesting that these patterns may be precursors to metastasis expansion and local spread from micrometastatic lesions. Combined, these findings demonstrate that PPM coupled to computational platforms is a powerful tool for analyzing ECM architecture that can be employed to advance cancer microenvironment studies and provide clinically relevant diagnostic information.                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nA new imaging technique called computationally enabled polychromatic polarized imaging (CEPP) has been developed to map the extracellular matrix (ECM) architectures that promote pancreatic ductal adenocarcinoma dissemination. CEPP uses machine learning and computational analysis to accurately capture these ECM patterns in histology sections, allowing for the identification of transitions from early to late-stage disease. This technique shows promise for advancing cancer microenvironment studies and providing clinically relevant diagnostic information.      1        0.969220                  1\n",
      "40330404                                                                         Role of Artificial Intelligence in the Diagnosis of Oral Squamous Cell Carcinoma: A Systematic Review. Oral squamous cell carcinoma (OSCC) is a serious worldwide health issue. Early OSCC identification by the analysis of digital oral photos is possible with the combination of artificial intelligence (AI) and computer vision. The purpose of this systematic review was to evaluate the current evidence on the role of AI in the diagnosis of OSCC, focusing on the diagnostic performance, methodologies employed, and potential limitations of AI applications in this context. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines to search for relevant studies across PubMed, Scopus, Web of Science, and Cumulative Index to Nursing and Allied Health Literature (CINAHL). In these databases, we found 286 studies, which were first screened for duplicates and then assessed on inclusion and exclusion criteria. Only 11 studies were found most relevant and were included in this study. These studies were also assessed for risk of bias using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tool. Numerous studies have shown impressive results for this job, frequently covering about 1000 photos and regularly reaching sensitivity rates above 85% with accuracy rates above 90%. The review examines these research in detail, providing insight into their methods, which include the application of contemporary machine learning and pattern recognition techniques in conjunction with various supervision techniques. However, because various datasets are utilized in different articles, it can be difficult to compare the results. In light of these results, this study emphasizes how urgently the area of OSCC detection needs more solid and trustworthy datasets. Additionally, it emphasizes how sophisticated methods like ensemble learning, multi-task learning, and attention mechanisms can be used as essential instruments to improve the sensitivity and accuracy of OSCC identification in oral photos. Together, these observations highlight how AI-driven methods for early OSCC diagnosis have the potential to greatly enhance patient outcomes and medical procedures.                                                                                                                     Here is a 2-3 sentence summary of the article:\\n\\nA systematic review evaluated the role of artificial intelligence (AI) in diagnosing oral squamous cell carcinoma (OSCC) from digital oral photos. The results showed that AI-driven methods can achieve high sensitivity rates (above 85%) and accuracy rates (above 90%) in identifying OSCC, with many studies using machine learning and pattern recognition techniques. However, the review also emphasized the need for more robust and trustworthy datasets to improve comparison of results and further enhance the potential of AI-driven methods in early OSCC diagnosis.      1        0.458124                  0\n",
      "40325252                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Screening of pivotal oncogenes modulated by DNA methylation in hepatocellular carcinoma and identification of atractylenolide I as an anti-cancer drug. This study was performed to identify crucial oncogenes modulated by DNA methylation in hepatocellular carcinoma (HCC) and look for new drugs for HCC treatment. The data of TCGA-LIHC cohort were obtained from UCSC database. Weighted gene co-expression network analysis and multiple machine learning algorithms were applied to screen the crucial prognosis-related genes in HCC. Then these genes were further screened by DNA methylation status. Ten-eleven translocation 1 (TET1) was overexpressed in HCC cell lines, and its biological functions and regulatory effects on the oncogenes were explored by qPCR, methylation-specific polymerase chain reaction, cell viability assay, Western blot, etc. Molecular docking was applied to evaluate the binding affinity between atractylenolide I (AT-I) and TET1, and the tumor-suppressive functions of AT-I were examined with both in vitro and in vivo models. In this work, 12 crucial genes related to HCC prognosis were obtained, among which six genes were with differential methylation status in HCC tissues, including AKR1B10, ALPK3, NQO1, NT5DC2, SFN, and SPP1. The expression levels of ALPK3 and NT5DC2 were positively regulated by TET1, the crucial mediator of demethylation. TET1 overexpression increased the viability and stemness of HCC cells. AT-I had good binding affinity with TET1, and repressed its activity. AT-I promoted the methylation of ALPK3 and NT5DC2 promoter regions, and reduced their expression, and repressed the growth of HCC cells. In summary, DNA methylation contributes to HCC progression, and AT-I represses the malignancy of HCC cells by inhibiting TET1-mediated abnormal DNA demethylation.                                                                                                                                                                                                                                       Here is a 2-3 sentence summary of the article:\\n\\nResearchers identified 12 genes associated with hepatocellular carcinoma (HCC) prognosis, including six that had different methylation statuses in HCC tissues. One of these genes, TET1, was overexpressed in HCC cell lines and played a role in regulating other oncogenes. A compound called atractylenolide I was found to bind to TET1, inhibit its activity, and promote the methylation of certain gene promoters, leading to reduced cancer cell growth.      0        0.027336                  0\n",
      "40320652                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Preclinical Evaluation of an Interactive Image Search System of Oral Pathology. The limited number of specialists and diseases' long-tail distribution create challenges in diagnosing oral tumors. Health care facilities with sole practicing pathologists face difficulties when encountering the rare cases. Such specialists may lack prior exposure to uncommon presentations, needing external reference materials to formulate accurate diagnoses. An image search or content-based image retrieval (CBIR) system may help diagnose rare tumors by providing histologically similar reference images, thus reducing the pathologists' workload. However, the effectiveness of CBIR systems in aiding pathologists' diagnoses through interactive use has not been evaluated. We conducted a remote evaluation in a near-clinical environment using Luigi-Oral, an interactive patch-based CBIR system that uses deep learning to diagnose oral tumors. The database comprised 54,676 image patches at multiple magnifications from 603 cases across 85 oral tumor categories. We recruited 15 general pathologists and 13 oral pathologists with varied experience to evaluate 10 retrospective test cases from 2 institutions using this dedicated system. At top-1 and top-3 differential diagnoses, the overall diagnostic accuracy among the 2 groups was significantly higher with Luigi-Oral than without (12.05% and 21.61% increase,                                                                                                                                                                                                              Here is a summary of the article in 3 sentences:\\n\\nThe diagnosis of rare oral tumors can be challenging due to the limited number of specialists and long-tail distribution of diseases. An interactive image search system, Luigi-Oral, was developed to provide histologically similar reference images to aid pathologists in diagnosing rare cases. In a preclinical evaluation, the system improved diagnostic accuracy among both general and oral pathologists, with significant increases in top-1 and top-3 differential diagnoses.      0        0.043636                  0\n",
      "40319974                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    IR-MBiTCN: Computational prediction of insulin receptor using deep learning: A multi-information fusion approach with multiscale bidirectional temporal convolutional network. The insulin receptor (IR) is a transmembrane protein that controls glucose homeostasis and is highly associated with chronic diseases including cancer and neurological. Traditional experimental methods have provided essential insights into IR structure and function, but they are constrained by time, cost, and scalability. To address these limitations, we present a computational technique for IR prediction based on deep learning and multi-information fusion. First, we built sequence-based training and testing datasets. Second, the compositional, word embedding, and evolutionary features were retrieved using the Weighted-Group Dipeptide Composition (W-GDPC), FastText, and Bi-Block-Position Specific Scoring Matrix (BB-PSSM), respectively. Third, we use compositional, word embedding, and evolutionary features to generate multi-perspective fused features (MPFF). Fourth, the Multiscale Bidirectional Temporal Convolutional Network (MBiTCN) is used to train the model to process features at multiscale and analyze sequences in both forward and backward directions. The proposed approach (IR-MBiTCN) outperforms competing deep learning (DL) and machine learning (ML)-based models on training and testing datasets, achieving 83.50 % and 79.43 % accuracy, respectively. This study represents a pioneering use of computational methodology in IR prediction, providing a scalable, efficient alternative to experimental procedures and paving the way for advances in chronic disease therapy and drug discovery.                                                                                                                                                                                              Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a deep learning-based approach called IR-MBiTCN to predict the structure and function of insulin receptors (IRs). The method combines multiple features from sequence, compositional, word embedding, and evolutionary data using a multiscale bidirectional temporal convolutional network. This approach outperformed other machine learning and deep learning models in predicting IRs, with an accuracy of 83.50% on the training dataset and 79.43% on the testing dataset.      0        0.643562                  1\n",
      "40356851                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Artificial intelligence-driven clinical decision support systems for early detection and precision therapy in oral cancer: a mini review. Oral cancer (OC) is a significant global health burden, with life-saving improvements in survival and outcomes being dependent on early diagnosis and precise treatment planning. However, diagnosis and treatment planning are predicated on the synthesis of complicated information derived from clinical assessment, imaging, histopathology and patient histories. Artificial intelligence-based clinical decision support systems (AI-CDSS) provides a viable solution that can be implemented via advanced methodologies for data analysis, and synthesis for better diagnostic and prognostic evaluation. This review presents AI-CDSS as a promising solution through advanced methodologies for comprehensive data analysis. In addition, it examines current implementations of AI-CDSS that facilitate early OC detection, precise staging, and personalized treatment planning by processing multimodal patient information through machine learning, computer vision, and natural language processing. These systems effectively interpret clinical results, identify critical disease patterns (including clinical stage, site, tumor dimensions, histopathologic grading, and molecular profiles), and construct comprehensive patient profiles. This comprehensive AI-CDSS approach allows for early cancer detection, a reduction in diagnostic delays and improved intervention outcomes. Moreover, the AI-CDSS also optimizes treatment plans on the basis of unique patient parameters, tumor stages and risk factors, providing personalized therapy.                                                    Here is a summary of the article in 2-3 sentences:\\n\\nArtificial intelligence-driven clinical decision support systems (AI-CDSS) have the potential to improve early detection and precision therapy for oral cancer. These systems use advanced data analysis and synthesis techniques to process multimodal patient information, such as imaging, histopathology, and patient histories, to identify critical disease patterns and construct comprehensive patient profiles. By leveraging machine learning, computer vision, and natural language processing, AI-CDSS can facilitate early diagnosis, personalized treatment planning, and improved intervention outcomes for oral cancer patients.      1        0.638336                  1\n",
      "40324114                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Training, Validating, and Testing Machine Learning Prediction Models for Endometrial Cancer Recurrence. Endometrial cancer (EC) is the most common gynecologic cancer in the United States with rising incidence and mortality. Despite optimal treatment, 15%-20% of all patients will recur. To better select patients for adjuvant therapy, it is important to accurately predict patients at risk for recurrence. Our objective was to train, validate, and test models of EC recurrence using lasso regression and other machine learning (ML) and deep learning (DL) analytics in a large, comprehensive data set.                                                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nEndometrial cancer is the most common gynecologic cancer in the US, with 15-20% of patients experiencing recurrence despite optimal treatment. To improve patient selection for adjuvant therapy, the objective was to develop machine learning models that accurately predict patients at risk of recurrence using a large dataset. The study used lasso regression and other machine learning/deep learning analytics to train, validate, and test these predictive models.      1        0.999377                  1\n",
      "40331556                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            BCD-TransNet: Automatic breast cancer detection and classification using transfer learning approach. Breast Cancer (BC) is a predominant form of cancer diagnosed in women and one of the deadliest diseases. The important cause of death owing to the cancer amongst women is BC. However, the existing ML techniques are very challenge evaluate the performance of the classification of BC and difficult task for early diagnosis. To overcome this challenge, transfer learning framework have been broadly applied to histopathological images for classifying tumour. So, in this research a novel BC Detection using Transfer learning network (BCD-TransNet) is introduced to identify and classify BC stages. Initially, the histopathological images from BreakHis dataset are pre-processed using stationary wavelet based Retinex (SWR) for eliminating the noise and progress the image quality. The noise-free images are segmented using the Hybrid Greedy Snake-Krill Herd Optimization (HGS-KHO) algorithm. The BCD-TransNet model that incorporates with five different pre-trained networks in which the knowledge attained by each model is transfer to next network for extracting the most relevant features. This detection model has two different phases namely first level classification for identifying benign and malignant cells and the second level classification for identifying the different types in benign and malignant. Finally, the ML-based Decision tree is used to detect the stages of breast tumour. From the simulation analysis, the BCD-TransNet present well accuracy of 99.31% for the classification of breast tumour. The proposed Transfer learning-based BCD-TransNet model improves the overall accuracy 2.11%, 13.31%, 1.82% better than DLA-EABA, Pa-DBN-BC, TTCNN respectively                                                                                                      Here is a summary of the article in 3 sentences:\\n\\nThe authors propose a novel transfer learning-based network called BCD-TransNet for automatic breast cancer detection and classification from histopathological images. The model uses a pre-processing step to remove noise and segment images using the Hybrid Greedy Snake-Krill Herd Optimization algorithm, followed by two levels of classification and finally, a decision tree to detect tumor stages. The simulation analysis shows that BCD-TransNet achieves an accuracy of 99.31% for breast cancer classification, outperforming other existing models by 2.11%, 13.31%, and 1.82%.      1        0.999883                  1\n",
      "40369044                                                                                                                                                                                                                                                                                                                                                                                                 Automated high precision PCOS detection through a segment anything model on super resolution ultrasound ovary images. PCOS (Poly-Cystic Ovary Syndrome) is a multifaceted disorder that often affects the ovarian morphology of women of their reproductive age, resulting in the development of numerous cysts on the ovaries. Ultrasound imaging typically diagnoses PCOS, which helps clinicians assess the size, shape, and existence of cysts in the ovaries. Nevertheless, manual ultrasound image analysis is often challenging and time-consuming, resulting in inter-observer variability. To effectively treat PCOS and prevent its long-term effects, prompt and accurate diagnosis is crucial. In such cases, a prediction model based on deep learning can help physicians by streamlining the diagnosis procedure, reducing time and potential errors. This article proposes a novel integrated approach, QEI-SAM (Quality Enhanced Image - Segment Anything Model), for enhancing image quality and ovarian cyst segmentation for accurate prediction. GAN (Generative Adversarial Networks) and CNN (Convolutional Neural Networks) are the most recent cutting-edge innovations that have supported the system in attaining the expected result. The proposed QEI-SAM model used Enhanced Super Resolution Generative Adversarial Networks (ESRGAN) for image enhancement to increase the resolution, sharpening the edges and restoring the finer structure of the ultrasound ovary images and achieved a better SSIM of 0.938, PSNR value of 38.60 and LPIPS value of 0.0859. Then, it incorporates the Segment Anything Model (SAM) to segment ovarian cysts and achieve the highest Dice coefficient of 0.9501 and IoU score of 0.9050. Furthermore, Convolutional Neural Network - ResNet 50, ResNet 101, VGG 16, VGG 19, AlexNet and Inception v3 have been implemented to diagnose PCOS promptly. Finally, VGG 19 has achieved the highest accuracy of 99.31%.                                                                                                                            Here is a summary of the article in 2-3 sentences:\\n\\nA new model called QEI-SAM (Quality Enhanced Image - Segment Anything Model) was developed for accurate diagnosis of Polycystic Ovary Syndrome (PCOS) using ultrasound images. The model uses Generative Adversarial Networks and Convolutional Neural Networks to enhance image quality, segment ovarian cysts, and predict PCOS diagnosis with high accuracy. The proposed approach achieved a high Dice coefficient and IoU score for cyst segmentation, and the best performing neural network for PCOS diagnosis was found to be VGG 19 with an accuracy of 99.31%.      1        0.401195                  0\n",
      "40336661                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Prediction of High-Dose Methotrexate Blood Concentration in Osteosarcoma Patients Using Machine Learning. High-dose methotrexate is a typical chemotherapy that is widely used in the treatment of osteosarcoma. However, the unique dose-response relationship of methotrexate makes its treatment window relatively narrow, and its clinical use is in a dilemma: either the drug concentration in the patient's body cannot reach the effective concentration level, or adverse reactions may occur due to drug overdose. For this circumstance, monitoring and predicting the drug concentration in the patient's body is well founded and necessary. While pharmacokinetic models exist, they often oversimplify patient-specific covariates. This study addresses the unmet need for early-exposure prediction through interpretable machine learning, enabling data-driven decisions before toxicity manifestation.                                                                                                                                                                                        Here is a summary of the article in 2-3 sentences:\\n\\nHigh-dose methotrexate chemotherapy is commonly used to treat osteosarcoma, but its narrow treatment window makes it challenging to achieve effective concentrations without adverse reactions. To address this issue, researchers developed a machine learning model that can predict blood concentration levels and enable data-driven decisions before toxicity occurs. This approach uses interpretable machine learning to account for patient-specific factors, improving the accuracy of predictions.      1        0.945616                  1\n",
      "40366616                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Identification of a Biomarker Panel in Extracellular Vesicles Derived From Non-Small Cell Lung Cancer (NSCLC) Through Proteomic Analysis and Machine Learning. Antigen fingerprint profiling of tumour-derived extracellular vesicles (TDEVs) in the body fluids is a promising strategy for identifying tumour biomarkers. In this study, proteomic and immunological assays reveal significantly higher CD155 levels in plasma extracellular vesicles (EVs) from patients with non-small cell lung cancer (NSCLC) than from healthy individuals. Utilizing CD155 as a bait protein on the EV membrane, CD155+ TDEVs are enriched from NSCLC patient plasma EVs. In the discovery cohort, 281 differentially expressed proteins are identified in TDEVs of the NSCLC group compared with the healthy control group. In the verification cohort, 49 candidate biomarkers are detected using targeted proteomic analysis. Of these, a biomarker panel of seven frequently and stably detected proteins-MVP, GYS1, SERPINA3, HECTD3, SERPING1, TPM4, and APOD-demonstrates good diagnostic performance, achieving an area under the curve (AUC) of 1.0 with 100% sensitivity and specificity in receiver operating characteristic (ROC) curve analysis, and 92.3% sensitivity and 88.9% specificity in confusion matrix analysis. Western blotting results confirm upregulation trends for MVP, GYS1, SERPINA3, HECTD3, SERPING1 and APOD, and TPM4 is downregulated in EVs of NSCLC patients compared with healthy individuals. These findings highlight the potential of this biomarker panel for the clinical diagnosis of NSCLC.                                                                                                                                                                                                                                                                               Here is a summary of the article in 2-3 sentences:\\n\\nA new biomarker panel was identified through proteomic analysis and machine learning, which may help diagnose non-small cell lung cancer (NSCLC). The panel consists of seven proteins: MVP, GYS1, SERPINA3, HECTD3, SERPING1, TPM4, and APOD. This biomarker panel demonstrated excellent diagnostic performance, with 100% sensitivity and specificity in a receiver operating characteristic (ROC) curve analysis.      1        0.674472                  1\n",
      "40318161                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Proteomics-Empowered Microfluidic-SERS Immunoassay for Identifying and Detecting Biomarkers of Micropapillary Lung Adenocarcinoma. The presence of a micropapillary (MPP) component is a crucial determinant of surgical strategies for lung adenocarcinoma (LUAD), yet reliable blood biomarkers for predicting MPP⁺ LUAD remain elusive. Here, we integrate 4D label-free quantitative proteomics, a nanomixing-enhanced microfluidic surface-enhanced Raman spectroscopy (SERS) platform, and machine learning to sensitively identify and validate blood protein biomarkers associated with MPP⁺ LUAD. Comparative proteomics reveal 44 differentially expressed proteins (DEPs) between MPP⁺ and MPP⁻ LUADs, with bioinformatics uncovering their roles in MPP⁺ LUAD formation. To enable sensitive, multiplex detection of 4 upregulated DEPs, the nanomixing effect is leveraged to enhance target protein-SERS barcode interactions while minimizing nonspecific binding to antibody-functionalized gold electrodes. The SERS barcode cocktail allows simultaneous detection of the 4 selected DEPs. Machine learning models based on SERS detection effectively distinguish MPP⁺ from MPP⁻ LUAD patients, as well as LUAD patients from healthy donors. This approach demonstrates strong diagnostic potential for early, non-invasive MPP detection in LUAD, advancing nanotechnology-driven disease diagnosis and monitoring.                                                                                                                               Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a new immunoassay that uses microfluidic technology and surface-enhanced Raman spectroscopy (SERS) to detect biomarkers for micropapillary lung adenocarcinoma. The assay identified 4 proteins associated with MPP+ LUAD and enabled simultaneous detection of these proteins using SERS barcodes. Machine learning models based on the SERS data were able to effectively distinguish between MPP+ LUAD patients, MPP- LUAD patients, and healthy donors, demonstrating strong diagnostic potential for early and non-invasive MPP detection.      1        0.765275                  1\n",
      "40368116                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Protease engineering: Approaches, tools, and emerging trends. Engineered proteases with bespoke substrate specificities and activities can empower broad and innovative applications in biomedicine, mass spectrometry-based proteomics, and chemical and synthetic biology. This review provides an authoritative, topical, and detailed description and discussion of the directed evolution and high-throughput strategies designed to engineer the substrate specificity of proteases in E. coli, yeast, phage, and cell-free systems. Second, we discuss emerging protease engineering strategies that complement directed evolution, including antibody-protease fusions that enable proximity catalysis, and protease substrate specificity switching driven by exogenous protein-protein interactions. Lastly, we discuss principles for engineering split and autoinhibited proteases, which are key signal-processing modules in protein circuits. Overall, readers will gain a valuable understanding of the latest advances in protease engineering, focusing on methodologies and strategies that enable precise control of protease activity and specificity.                                                                                                        Here is a summary of the article in 2-3 sentences:\\n\\nThe article reviews the approaches, tools, and emerging trends in protease engineering, which enables the design of proteases with specific substrate preferences and activities. Directed evolution and high-throughput strategies are discussed as methods for engineering substrate specificity in various systems, including E. coli, yeast, phage, and cell-free systems. Additionally, the article touches on other emerging approaches, such as antibody-protease fusions and exogenous protein-protein interactions, which can be used to control protease activity and specificity.      0        0.000076                  0\n",
      "40348282                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Predicting Survival Outcomes in Renal Cell Carcinoma Spinal Metastases: A Multicenter Evaluation of Existing Prognostic Systems. Survival prediction models for patients with spinal metastases are crucial for guiding clinical decision-making and optimizing treatment strategies. Renal cell carcinoma (RCC) spinal metastases (RCC-SM) present unique challenges due to their distinct biological behavior and variable response to systemic therapies.                                                                                                                                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nPredicting survival outcomes for patients with renal cell carcinoma spinal metastases is crucial for informing clinical decisions and optimizing treatment strategies. Renal cell carcinoma spinal metastases (RCC-SM) pose unique challenges due to their distinct biological behavior and varied response to systemic therapies, making it important to develop reliable prediction models.      0        0.156426                  0\n",
      "40356764                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Different MRI-based radiomics machine learning models to predict CD3+ tumor-infiltrating lymphocytes in rectal cancer. This study aimed to develop and evaluate multiple machine learning models utilizing contrast-enhanced T1-weighted imaging (T1-CE) to differentiate between low-/high-infiltration of total T lymphocytes (CD3) in patients with rectal cancer.                                                                                                                                                                                                                                                                                                                                                                         Here is a summary of the article:\\n\\nResearchers developed and tested various machine learning models using magnetic resonance imaging (MRI) data to predict the presence of CD3+ tumor-infiltrating lymphocytes (TILs) in patients with rectal cancer. The goal was to differentiate between low- and high-infiltration levels based on contrast-enhanced T1-weighted MRI scans.      1        0.999780                  1\n",
      "40337276                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Integration of histopathological image features and multi-dimensional omics data in predicting molecular features and survival in glioblastoma. Glioblastoma (GBM) is a highly malignant brain tumor with complex molecular mechanisms. Histopathological images provide valuable morphological information of tumors. This study aims to evaluate the predictive potential of quantitative histopathological image features (HIF) for molecular characteristics and overall survival (OS) in GBM patients by integrating HIF with multi-omics data.                                                                                                                                                                                                           Here is a summary of the article in 2-3 sentences:\\n\\nThe study aimed to investigate whether integrating histopathological image features with multi-dimensional omics data could predict molecular features and survival outcomes in glioblastoma (GBM) patients. Histopathological images were used to extract quantitative features, which were then combined with omics data to evaluate their predictive power for GBM patient outcomes. The goal was to identify potential biomarkers for molecular characteristics and overall survival.      1        0.992971                  1\n",
      "40361437                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Evolving and Novel Applications of Artificial Intelligence in Cancer Imaging. Artificial intelligence (AI) is revolutionizing cancer imaging, enhancing screening, diagnosis, and treatment options for clinicians. AI-driven applications, particularly deep learning and machine learning, excel in risk assessment, tumor detection, classification, and predictive treatment prognosis. Machine learning algorithms, especially deep learning frameworks, improve lesion characterization and automated segmentation, leading to enhanced radiomic feature extraction and delineation. Radiomics, which quantifies imaging features, offers personalized treatment response predictions across various imaging modalities. AI models also facilitate technological improvements in non-diagnostic tasks, such as image optimization and automated medical reporting. Despite advancements, challenges persist in integrating AI into healthcare, tracking accurate data, and ensuring patient privacy. Validation through clinician input and multi-institutional studies is essential for patient safety and model generalizability. This requires support from radiologists worldwide and consideration of complex regulatory processes. Future directions include elaborating on existing optimizations, integrating advanced AI techniques, improving patient-centric medicine, and expanding healthcare accessibility. AI can enhance cancer imaging, optimizing precision medicine and improving patient outcomes. Ongoing multidisciplinary collaboration between radiologists, oncologists, software developers, and regulatory bodies is crucial for AI's growing role in clinical oncology. This review aims to provide an overview of the applications of AI in oncologic imaging while also discussing their limitations.                                                                                  Here is a summary of the article in 3 sentences:\\n\\nArtificial intelligence (AI) is transforming cancer imaging by enhancing screening, diagnosis, and treatment options for clinicians. AI-driven applications excel in risk assessment, tumor detection, classification, and predictive treatment prognosis, as well as lesion characterization and automated segmentation. Despite challenges persisting in integrating AI into healthcare, the potential benefits of AI in oncologic imaging include optimizing precision medicine and improving patient outcomes, making ongoing multidisciplinary collaboration crucial for its growing role in clinical oncology.      1        0.994954                  1\n",
      "40359715                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Breast cancer neoadjuvant therapy outcome prediction based on clinical patient and tumor features: A cross-sectional study. Breast cancer is the most common malignant disease in the female population and one of the most common diseases in developed countries. Many factors which may impact the development and outcome of this complex disease have been investigated. The aim of this study was to analyze factors that affect neoadjuvant therapy outcomes and create an outcome prediction model based on these factors.                                                                                                                                                                                                                                                                                                                                                                                            Here is a summary of the article in 2-3 sentences:\\n\\nThe article discusses the most common malignant disease affecting women, breast cancer, which has many influencing factors. The goal of this study was to identify factors that impact the outcome of neoadjuvant therapy (pre-surgery treatment) and develop a predictive model based on these factors.      0        0.004199                  0\n",
      "40369585                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Optimizing breast lesions diagnosis and decision-making with a deep learning fusion model integrating ultrasound and mammography: a dual-center retrospective study. This study aimed to develop a BI-RADS network (DL-UM) via integrating ultrasound (US) and mammography (MG) images and explore its performance in improving breast lesion diagnosis and management when collaborating with radiologists, particularly in cases with discordant US and MG Breast Imaging Reporting and Data System (BI-RADS) classifications.                                                                                                                                                                                                                                                                                                                                              Here is a 2-3 sentence summary of the article:\\n\\nA deep learning fusion model was developed to integrate ultrasound and mammography images for breast lesion diagnosis and management. The model, called DL-UM, aimed to improve diagnostic accuracy by combining information from both imaging modalities, particularly in cases where there were discordant diagnoses between ultrasound and mammography.      1        0.975096                  1\n",
      "40365297                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Optimizing theranostics chatbots with context-augmented large language models.                                                                                                                                                          The article discusses the potential of combining context-augmented large language models (LLMs) with theranostic chatbots to improve patient engagement and healthcare outcomes. Theranostic chatbots are AI-powered platforms that provide personalized health information and support, while LLMs can enhance their ability to understand patients' needs and provide more accurate and relevant information. By integrating these two technologies, the article suggests that theranostic chatbots can become even more effective in supporting patients throughout their healthcare journeys.      0        0.061662                  0\n",
      "40347229                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         ESR Bridges: lung cancer: new developments in imaging and treatment-a multidisciplinary view.                                                                                                                    The article \"ESR Bridges: lung cancer: new developments in imaging and treatment-a multidisciplinary view\" provides an overview of recent advancements in imaging and treatment options for lung cancer, a disease that is increasingly common and deadly. The piece highlights the importance of a multidisciplinary approach, combining expertise from radiology, oncology, surgery, and pathology to improve patient outcomes. It also discusses innovative imaging techniques, such as computed tomography (CT) scans and positron emission tomography (PET), which can aid in early detection and accurate staging of lung cancer.      0        0.287357                  0\n",
      "40329352                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Computational analysis of whole slide images predicts PD-L1 expression and progression-free survival in immunotherapy-treated non-small cell lung cancer patients. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by significantly improving the efficacy of treatments and tolerability for patients with non-small cell lung cancer (NSCLC). However, even after meticulous selection based on molecular criteria, only 20-30% of the patients respond to ICIs. This highlights the urgent clinical need to develop more precise biomarkers to better identify individuals who will benefit from these expensive therapies.                                                                                                                                                                                                                                                                                                                                 Here is a summary of the article in 2-3 sentences:\\n\\nResearchers used computational analysis of whole slide images to predict PD-L1 expression and progression-free survival in non-small cell lung cancer patients treated with immune checkpoint inhibitors (ICIs). Despite careful selection based on molecular criteria, only 20-30% of patients respond to ICIs, highlighting the need for more precise biomarkers.      1        0.866883                  1\n",
      "40364006                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     New Evidence About Malignant Transformation of Endometriosis-A Systematic Review.                                                                                                                                                                                                                                                                                                                                                                                                                                                         I'm happy to summarize an article for you! However, I don't see a specific article provided with the title \"New Evidence About Malignant Transformation of Endometriosis-A Systematic Review.\" Would you like me to provide a general summary about endometriosis and its potential risks instead?      0        0.000232                  0\n",
      "40343502                                                                                                                                                                                                                                                            Development of a prognostic model for osteosarcoma based on macrophage polarization-related genes using machine learning: implications for personalized therapy. While neoadjuvant chemotherapy combined with surgical resection has improved the prognosis for patients with osteosarcoma, its impact on metastatic and recurrent cases remains limited. Immunotherapy is emerging as a promising alternative. However, the relationship between the phenotype of tumor-associated macrophages and the prognosis of osteosarcoma remains unclear. Differentially expressed gene during macrophage polarization were identified using the Monocle package. Weighted gene co-expression network analysis was conducted to select genes regulating macrophage polarization. The least absolute shrinkage and selection operator algorithm and multivariate Cox regression were used to construct long-term survival predictive strategies. Multiple machine learning algorithms identified target genes for pan-cancer analysis. Lentiviral transfection created stable strains with target gene knockdown, and CCK-8 and transwell migration assays verified the target gene's effects. Western blot and flow cytometry assessed the impact of target genes on macrophage polarization. A total of 141 genes regulating macrophage polarization were identified, from which eight genes were selected to construct prognostic models. Significant differences between high-risk and low-risk groups were observed in immune cell activation, immune-related signaling pathways, and immune function. The prognostic model and target gene were validated to provide more precise immunotherapy options for osteosarcoma and other tumors. BNIP3 knockdown decreased osteosarcoma cell proliferation and migration and promoted macrophage polarization to the M2 phenotype. The constructed prognostic model offers precise immunotherapy regimens and valuable insights into mechanisms underlying current studies. Furthermore, BNIP3 may serve as a potential immunotherapeutic target for osteosarcoma and other tumors.                                                                                                                                    Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a predictive model for osteosarcoma prognosis based on genes related to macrophage polarization using machine learning algorithms. The study identified 141 genes regulating macrophage polarization, from which eight were selected to construct prognostic models that showed significant differences between high-risk and low-risk groups in immune cell activation and function. The findings suggest that targeting specific genes, such as BNIP3, may provide more precise immunotherapy options for osteosarcoma and other tumors.      1        0.924034                  1\n",
      "40325103                                                                                                                                                                                                                                   Advanced holographic convolutional dense networks and Tangent runner optimization for enhanced polycystic ovarian disease classification. Polycystic Ovarian Disease (PCOD) is among the most prevalent endocrine disorders complicating the health of innumerable women worldwide due to lack of diagnosis and appropriate management. The diagnosis of PCOD, along with proper classification with the help of ultrasound imaging, would be of immense importance for early intervention and timely management of the condition. However, most of the existing approaches suffer from lots of problems, including low accuracy and capability in feature extraction, and may also be resilient to noise; it can further delay or lead to a wrong diagnosis. The main objective of this paper is to address these important issues by proposing a deep learning model, Holographic Convolutional Dense Network (Coco-HoloNet) that will be tailored for the precise detection and classification of PCOD in ultrasound images with high accuracy. These are multi-fold contributions which focus on improvement in diagnostic accuracy by overcoming the various limitations of conventional approaches. CoCo-HoloNet is using a layered architecture by integrating convolutional layers, dense blocks, and pooling strategies that leverage capturing and extraction of significant features from the input effectively. More importantly, the model is also embedded with the Tangent-Runner Adaptive Optimization (TRAdO) technique, which dynamically calculates the regularization parameters to overcome overfitting problems and improves the generalization capability of the model. The approach not only ensures the richest possible feature representation, but it also results in outstanding improvements within the performance measures of a model, such that the accuracy rate exceeds 99%. Further experimentation with CoCo-HoloNet on an extended Kaggle PCOD ultrasound image dataset proves its effectiveness by reporting higher precision, recall, and F1-scores than those obtained by state-of-the-art existing methods. Here is a summary of the article in 2-3 sentences:\\n\\nThe paper proposes a deep learning model called Holographic Convolutional Dense Network (CoCo-HoloNet) to accurately diagnose and classify Polycystic Ovarian Disease (PCOD) from ultrasound images. The CoCo-HoloNet model uses a layered architecture with convolutional layers, dense blocks, and pooling strategies to extract significant features from the input, and is embedded with the Tangent-Runner Adaptive Optimization technique to overcome overfitting problems. As a result, the model achieves an accuracy rate exceeding 99% on an extended Kaggle PCOD ultrasound image dataset, outperforming existing state-of-the-art methods in terms of precision, recall, and F1-scores.      1        0.960847                  1\n",
      "40366574                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Development and Validation of a Machine Learning-Based Predictive Model for Postoperative Frailty in Patients with Non-Small Cell Lung Cancer and Its Relation to Early Recovery. This study was designed to evaluate the postoperative frailty status of patients with non-small cell lung cancer, identify influencing factors, establish a machine learning-based prediction model, and explore the correlation between frailty status at 3 months and early recovery at 1 month postoperatively.                                                                                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a machine learning-based predictive model to assess postoperative frailty in patients with non-small cell lung cancer, aiming to identify factors that influence frailty status and explore its relationship with early recovery. The study aimed to evaluate postoperative frailty, establish a predictive model, and examine the correlation between frailty at 3 months and early recovery at 1 month after surgery.      0        0.676685                  1\n",
      "40348987                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              A novel framework for esophageal cancer grading: combining CT imaging, radiomics, reproducibility, and deep learning insights. This study aims to create a reliable framework for grading esophageal cancer. The framework combines feature extraction, deep learning with attention mechanisms, and radiomics to ensure accuracy, interpretability, and practical use in tumor analysis.                                                                                                                                                                                                                                                             Here is a summary of the article in 2-3 sentences:\\n\\nA new approach has been developed to grade esophageal cancer using a combination of computed tomography (CT) imaging, radiomics, reproducibility, and deep learning insights. This framework aims to provide an accurate, interpretable, and practical method for tumor analysis. By combining feature extraction, attention-based deep learning, and radiomics, the goal is to create a reliable grading system for esophageal cancer.      1        0.981807                  1\n",
      "40368928 Performance of MRI-based radiomics for prediction of residual disease status in patients with nasopharyngeal carcinoma after radical radiotherapy. The purpose of this study was to determine if habitat radiomic features extracted from pretherapy multi-sequence MRI predict residual status in patients with Nasopharyngeal Carcinoma (NPC) after radical radiotherapy. The retrospective study enrolled 179 primary NPC patients, divided into training and validation cohorts at a 7:3 ratio. K-means clustering was employed to segment T2WI, CE-T1WI and FSCE-T1WI images, creating habitats within the volume of interest. Identify relevant features that can recognize NPC residuals. In the training cohort, support vector machine (SVM) models were developed utilizing the radiomic features extracted from each habitat and the entire tumor, selecting the most predictive features for each sequence. SVM models were constructed by combining the optimal radiomic features from each sequences with clinical data. Model performance was compared and validated using receiver operating characteristic (ROC) curves, calibration curves and decision curve analysis (DCA), and differences between models were assessed using the DeLong test. The optimal clustering results revealed 4 habitats in FSCE-T1WI, while 2 habitats in both CE-T1WI and T2WI sequences. In the training cohort, we compared the predictive accuracy of SVM models based on different habitats and total tumor characteristics from three sequences, and found that the features from T2 Hab2, CE-T1 Hab1, and FSCE-T1 Hab4 images showed higher performance. Incorporation of habitat-based radiomic features and clinical variables significantly enhanced the predictive performance. The integrated model exhibits the optimal predictive performance, with the area under the curve (AUC) values of 0.921 (SEN = 0.821, SPE = 0.830) in the training cohort and 0.811 (SEN = 0.778, SPE = 0.722) in the validation cohort. Compared to conventional radiomics, habitat imaging features that distinguish intratumoral heterogeneity have higher predictive value, making them potential non-invasive biomarkers for assessing NPC residual after radiotherapy. Integration of multi-sequence MRI habitat radiomic with clinical parameters further improved predictive accuracy.                                                                                                                                                 Here is a summary of the article in 2-3 sentences:\\n\\nResearchers used magnetic resonance imaging (MRI) to develop a radiomics model that can predict the presence of residual disease in patients with nasopharyngeal carcinoma after radiation therapy. The model, which incorporates features from different MRI sequences and habitats within the tumor, showed high predictive accuracy in both training and validation cohorts. The integrated model outperformed conventional radiomics models and may serve as a non-invasive biomarker for assessing residual disease status after radiotherapy.      1        0.995471                  1\n",
      "40331540                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 Advancing brain tumor detection and classification in Low-Dose CT images using the innovative multi-layered deep neural network model. BackgroundEffective brain tumour therapy and better patient outcomes depend on early tumour diagnosis. Accurate diagnosis can be hampered by traditional imaging techniques' frequent struggles with low resolution and noise, especially in Low Dose CT scans.                                                                                                                                                                                                                                                 Here is a summary of the article in 2-3 sentences:\\n\\nEarly and accurate detection of brain tumors is crucial for effective treatment and better patient outcomes. However, traditional imaging techniques often struggle to accurately diagnose tumors due to limitations such as low resolution and noise, particularly in Low-Dose CT scans. A new multi-layered deep neural network model has been developed to improve the detection and classification of brain tumors in these challenging images.      1        0.999407                  1\n",
      "40335825                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         MRI-based machine learning reveals proteasome subunit PSMB8-mediated malignant glioma phenotypes through activating TGFBR1/2-SMAD2/3 axis. Gliomas are the most prevalent and aggressive neoplasms of the central nervous system, representing a major challenge for effective treatment and patient prognosis. This study identifies the proteasome subunit beta type-8 (PSMB8/LMP7) as a promising prognostic biomarker for glioma. Using a multiparametric radiomic model derived from preoperative magnetic resonance imaging (MRI), we accurately predicted PSMB8 expression levels. Notably, radiomic prediction of poor prognosis was highly consistent with elevated PSMB8 expression. Our findings demonstrate that PSMB8 depletion not only suppressed glioma cell proliferation and migration but also induced apoptosis via activation of the transforming growth factor beta (TGF-β) signaling pathway. This was supported by downregulation of key receptors (TGFBR1 and TGFBR2). Furthermore, interference with PSMB8 expression impaired phosphorylation and nuclear translocation of SMAD2/3, critical mediators of TGF-β signaling. Consequently, these molecular alterations resulted in reduced tumor progression and enhanced sensitivity to temozolomide (TMZ), a standard chemotherapeutic agent. Overall, our findings highlight PSMB8's pivotal role in glioma pathophysiology and its potential as a prognostic marker. This study also demonstrates the clinical utility of MRI radiomics for preoperative risk stratification and pre-diagnosis. Targeted inhibition of PSMB8 may represent a therapeutic strategy to overcome TMZ resistance and improve glioma patient outcomes.                                                                                                                                                                    Here is a summary of the article in 2-3 sentences:\\n\\nResearchers used magnetic resonance imaging (MRI) and machine learning to identify the proteasome subunit beta type-8 (PSMB8) as a promising prognostic biomarker for gliomas. PSMB8 depletion was found to suppress glioma cell proliferation and migration, induce apoptosis, and impair phosphorylation of SMAD2/3, leading to reduced tumor progression and enhanced sensitivity to chemotherapy. These findings suggest that targeted inhibition of PSMB8 may be a therapeutic strategy to improve glioma patient outcomes.      0        0.916519                  1\n",
      "40340630                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Quantitative analysis and clinical determinants of orthodontically induced root resorption using automated tooth segmentation from CBCT imaging. Orthodontically induced root resorption (OIRR) is difficult to assess accurately using traditional 2D imaging due to distortion and low sensitivity. While CBCT offers more precise 3D evaluation, manual segmentation remains labor-intensive and prone to variability. Recent advances in deep learning enable automatic, accurate tooth segmentation from CBCT images. This study applies deep learning and CBCT technology to quantify OIRR and analyze its risk factors, aiming to improve assessment accuracy, efficiency, and clinical decision-making.                                                                                                                                                                                                                                      Here is a summary of the article in 2-3 sentences:\\n\\nOrthodontically induced root resorption (OIRR) is challenging to assess accurately using traditional 2D imaging methods. Computerized tomography (CBCT) offers a more precise 3D evaluation, but manual segmentation of CBCT images can be labor-intensive and prone to variability. A new study uses deep learning technology to automatically segment teeth from CBCT images, allowing for accurate quantification of OIRR and analysis of its risk factors.      0        0.008730                  0\n",
      "40347323                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Preferences for the Use of Artificial Intelligence for Breast Cancer Screening in Australia: A Discrete Choice Experiment. Breast cancer screening is considered an effective early detection strategy. Artificial intelligence (AI) may both offer benefits and create risks for breast screening programmes. To use AI in health screening services, the views and expectations of consumers are critical. This study examined the preferences of Australian women regarding AI use in breast cancer screening and the impact of information on preferences using discrete choice experiments.                                                                                                                                                                                                                    Here is a summary of the article in 2-3 sentences:\\n\\nThe effectiveness of breast cancer screening relies heavily on early detection, and the potential use of artificial intelligence (AI) to aid this process raises both benefits and risks. To successfully integrate AI into breast screening programs, it's crucial to understand the preferences of women regarding AI usage. This study investigated Australian women's views on using AI for breast cancer screening and how providing information affects their preferences.      0        0.139091                  0\n",
      "40352589                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Overexpression of MMP14 is associated with poor prognosis and immune cell infiltration in colon cancer. Colorectal cancer (CRC) poses a significant risk of recurrence and distant metastases. This study investigated the regulatory role of Matrix metalloproteinase-14 (                                                                                                                                                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nOverexpression of MMP14, a protein involved in tissue remodeling, is linked to poor prognosis and increased immune cell infiltration in colon cancer patients. Colorectal cancer has a high risk of recurrence and distant metastases. This study explored the regulatory role of MMP14 in colon cancer, suggesting that it may play a key part in the disease's progression.      0        0.075776                  0\n",
      "40349260                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Random forest-based model for the recurrence prediction of borderline ovarian tumor: clinical development and validation. This study aims to develop an effective machine learning (ML)-based predictive model for the recurrence of borderline ovarian tumor (BOT), and provide the guidelines of accurate clinical diagnosis and precise treatment for patients.                                                                                                                                                                                                                                                                                                                                                                                                 Here is a summary of the article in 2-3 sentences:\\n\\nThe study aimed to create a reliable machine learning-based model using random forests to predict the recurrence of borderline ovarian tumors (BOTs). The developed model was validated against clinical data, with the goal of providing accurate diagnoses and treatment guidelines for patients.      1        0.996084                  1\n",
      "40334987                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Artificial Intelligence in the Management of Malnutrition in Cancer Patients: A Systematic Review. Malnutrition is a critical complication among cancer patients, affecting up to 80% of individuals depending on cancer type, stage, and treatment. Artificial Intelligence (AI) has emerged as a promising tool in healthcare, with potential applications in nutritional management to improve early detection, risk stratification, and personalized interventions.                                                                                                                                                                                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nMalnutrition affects up to 80% of cancer patients, depending on factors such as cancer type, stage, and treatment. Artificial Intelligence (AI) has shown promise in healthcare, particularly in nutritional management, enabling early detection, risk stratification, and personalized interventions for cancer patients with malnutrition.      1        0.455128                  0\n",
      "40324259                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Establishment and validation of a novel risk model based on PANoptosis-related genes to predict prognosis in head and neck squamous cell carcinoma. Head and neck squamous cell carcinoma (HNSC) is a common cancer worldwide with poor prognosis. Current treatment methods have limited effect on improving the prognosis of patients with HNSC. Differentially expressed PANoptosis-related genes in HNSC were identified from the TCGA using limma and WGCNA. A prognostic model was established using univariate and multivariate Cox regression analyses and machine learning, and its performance was evaluated using Kaplan-Meier and receiver operating characteristic curves. SNP data was analyzed using maftools package. Immune analysis was performed using IOBR package and TIDE website. The scRNA data was analyzed using Seurat and cellchat package. The expression of hub genes was validated in vitro. The prognostic model comprising 5 hub PANoptosis-related genes (AIFM1, AKT3, CDKN2A, EGFR, IL1RAP) accurately predicted patient outcomes, with the high-risk group exhibiting poorer survival. mRNA expression levels of all 5 hub genes were elevated in the tumor cells, but only AIFM1, AKT3 and IL1RAP's protein expression were higher in tumor tissues. Additionally, high expression of AIFM1, AKT3, EGFR, IL1RAP and low expression of CDKN2A indicated poor prognosis of HNSC patients. The decreasing levels of CD4 T cells, CD8 T cells and M1 macrophages were observed in high-risk groups. There was a significant difference of 5-fluorouracil in low and high-risk groups. scRNA analysis exhibited that TNF pathway was important in the interaction between macrophages and T cells. We identified 5 hub genes and constructed a great risk model for the prognosis of HNSC. The immune cells may influence the HNSC malignant through TNF signal pathway.                                                                                                                                                                                       Here is a summary of the article in 2-3 sentences:\\n\\nA novel risk model was developed to predict the prognosis of head and neck squamous cell carcinoma (HNSCC) patients based on PANoptosis-related genes. The model, which included five hub genes (AIFM1, AKT3, CDKN2A, EGFR, and IL1RAP), accurately predicted patient outcomes and identified high-risk groups with poorer survival. Additionally, the study found that immune cells, such as T cells and macrophages, may influence HNSCC malignancy through the tumor necrosis factor (TNF) signal pathway.      0        0.055072                  0\n",
      "40369011                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  A multi-layered defense against adversarial attacks in brain tumor classification using ensemble adversarial training and feature squeezing. Deep learning, particularly convolutional neural networks (CNNs), has proven valuable for brain tumor classification, aiding diagnostic and therapeutic decisions in medical imaging. Despite their accuracy, these models are vulnerable to adversarial attacks, compromising their reliability in clinical settings. In this research, we utilized a VGG16-based CNN model to classify brain tumors, achieving 96% accuracy on clean magnetic resonance imaging (MRI) data. To assess robustness, we exposed the model to Fast Gradient Sign Method (FGSM) and Projected Gradient Descent (PGD) attacks, which reduced accuracy to 32% and 13%, respectively. We then applied a multi-layered defense strategy, including adversarial training with FGSM and PGD examples and feature squeezing techniques such as bit-depth reduction and Gaussian blurring. This approach improved model resilience, achieving 54% accuracy on FGSM and 47% on PGD adversarial examples. Our results highlight the importance of proactive defense strategies for maintaining the reliability of AI in medical imaging under adversarial conditions.                                                                                                                                                                             Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a multi-layered defense strategy to protect brain tumor classification models from adversarial attacks, achieving a 54% accuracy on Fast Gradient Sign Method (FGSM) and 47% on Projected Gradient Descent (PGD) attacked data. The approach combined ensemble adversarial training with feature squeezing techniques, such as bit-depth reduction and Gaussian blurring. This proactive defense strategy aims to maintain the reliability of AI in medical imaging under adversarial conditions.      1        0.930200                  1\n",
      "40341828                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Fusion-Brain-Net: A Novel Deep Fusion Model for Brain Tumor Classification. Brain tumors are among the most prevalent and lethal diseases. Early diagnosis and precise treatment are crucial. However, the manual classification of brain tumors is a laborious and complex task.                                                                                                                                                                                                                                                                                                                  Here is a summary of the article in 2-3 sentences:\\n\\nThe article discusses the development of Fusion-Brain-Net, a novel deep fusion model for classifying brain tumors. Brain tumors are a common and deadly disease, requiring early diagnosis and precise treatment. The manual classification of brain tumors is a time-consuming and complex task that can be improved through the use of advanced AI models like Fusion-Brain-Net.      1        0.706654                  1\n",
      "40356086                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            A systematic review and meta-analysis of lung cancer risk prediction models. Lung cancer (LC) remains the leading cause of cancer-related mortality worldwide. Early detection through targeted screening significantly improves patient outcomes. However, identifying high-risk individuals remains a critical challenge.                                                                                                                                                                                                                                          Here is a summary of the article in 2-3 sentences:\\n\\nLung cancer is the leading cause of cancer-related deaths globally and early detection through targeted screening can improve patient outcomes. Identifying high-risk individuals remains a significant challenge in lung cancer prevention, making accurate risk prediction models crucial. A systematic review and meta-analysis aims to assess the performance of existing lung cancer risk prediction models to better identify those at highest risk.      0        0.038469                  0\n",
      "40337768                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Development and validation of a basement membrane-associated immune prognostic model for hepatocellular carcinoma. Hepatocellular carcinoma (HCC), one of the most common malignant tumors worldwide, has a poor prognosis primarily due to its invasive and metastatic characteristics. Cancer invasion through basement membrane (BM) is the pivotal initial step in tumor dissemination and metastasis. This study aimed to identify gene signatures associated with the BM to enhance the overall prognosis of HCC.                                                                                                                                                                                                                                                                            Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed an immune prognostic model that focuses on basement membrane (BM) associations to improve the prognosis of hepatocellular carcinoma (HCC). The study aims to identify gene signatures linked to BM involvement, which is crucial for HCC's invasive and metastatic characteristics. By analyzing BM-associated genes, the model hopes to enhance overall prognosis outcomes for patients with HCC.      0        0.682181                  1\n",
      "40362602                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    A Transfer Learning Framework for Predicting and Interpreting Drug Responses via Single-Cell RNA-Seq Data. Chemotherapy is a fundamental therapy in cancer treatment, yet its effectiveness is often undermined by drug resistance. Understanding the molecular mechanisms underlying drug response remains a major challenge due to tumor heterogeneity, complex cellular interactions, and limited access to clinical samples, which also hinder the performance and interpretability of existing predictive models. Meanwhile, single-cell RNA sequencing (scRNA-seq) has emerged as a powerful tool for uncovering resistance mechanisms, but the systematic collection and utilization of scRNA-seq drug response data remain limited. In this study, we collected scRNA-seq drug response datasets from publicly available web sources and proposed a transfer learning-based framework to align bulk and single cell sequencing data. A shared encoder was designed to project both bulk and single-cell sequencing data into a unified latent space for drug response prediction, while a sparse decoder guided by prior biological knowledge enhanced interpretability by mapping latent features to predefined pathways. The proposed model achieved superior performance across five curated scRNA-seq datasets and yielded biologically meaningful insights through integrated gradient analysis. This work demonstrates the potential of deep learning to advance drug response prediction and underscores the value of scRNA-seq data in supporting related research.                                                                                                                                                 Here is a summary of the article in 2-3 sentences:\\n\\nResearchers developed a transfer learning framework that combines bulk and single-cell RNA sequencing data to predict and interpret drug responses. The model, which uses shared encoding and sparse decoding, achieved superior performance across five curated datasets and provided biologically meaningful insights through integrated gradient analysis. This work demonstrates the potential of deep learning to advance drug response prediction and highlights the value of single-cell RNA sequencing data in supporting related research.      1        0.831250                  1\n"
     ]
    }
   ],
   "source": [
    "# TRAIN NEURAL NETWORK, DISPLAY RESULTS \n",
    "\n",
    "\n",
    "# Assuming X_train, y_train, X_test, y_test, df_test are available from previous cell\n",
    "# Build and train model\n",
    "model = funny_guy()\n",
    "model.add(Layer_Dense(768, 32, weight_regularizer_l2=5e-4))\n",
    "model.add(Activation_ReLU())\n",
    "model.add(Layer_Dropout(0.25))\n",
    "model.add(Layer_Dense(32, 1, weight_regularizer_l2=5e-4))\n",
    "model.add(Activation_Sigmoid())\n",
    "model.set(\n",
    "    loss=Loss_BinaryCrossEntropy(),\n",
    "    optimizer=Optimizer_SGD(learning_rate=0.008, decay=2e-5, momentum=0.82),\n",
    "    accuracy=Accuracy_Binary()\n",
    ")\n",
    "model.finalize()\n",
    "\n",
    "# Train model\n",
    "history = model.train(X_train, y_train, epochs=28, batch_size=20, print_every=10, validation_data=(X_test, y_test))\n",
    "\n",
    "# Predict and add to test DataFrame\n",
    "predictions = model.predict(X_test)\n",
    "df_test['raw_prediction'] = predictions.flatten()\n",
    "df_test['binary_prediction'] = (predictions > 0.5).astype(int)\n",
    "\n",
    "# Display test DataFrame\n",
    "print(\"\\nTest DataFrame with Predictions:\")\n",
    "print(df_test.to_string(index=False))\n",
    "print(\"Confusion Matrix:\\n\", pd.crosstab(df_test['label'], df_test['binary_prediction']))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 1200x500 with 2 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "# PLOT RESULTS \n",
    "\n",
    "\n",
    "epochs_range = range(1, len(history['train_loss']) + 1)\n",
    "plt.figure(figsize=(12, 5))\n",
    "plt.subplot(1, 2, 1)\n",
    "plt.plot(epochs_range, history['train_loss'], label='Training Loss')\n",
    "plt.plot(epochs_range, history['val_loss'], label='Validation Loss')\n",
    "plt.xlabel('Epochs')\n",
    "plt.ylabel('Loss')\n",
    "plt.title('Loss Over Epochs')\n",
    "plt.legend()\n",
    "plt.grid(True)\n",
    "plt.subplot(1, 2, 2)\n",
    "plt.plot(epochs_range, history['train_acc'], label='Training Accuracy')\n",
    "plt.plot(epochs_range, history['val_acc'], label='Validation Accuracy')\n",
    "plt.xlabel('Epochs')\n",
    "plt.ylabel('Accuracy')\n",
    "plt.title('Accuracy Over Epochs')\n",
    "plt.legend()\n",
    "plt.grid(True)\n",
    "plt.tight_layout()\n",
    "plt.show()\n",
    "\n"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "At 250 samples, validation loss and training loss further decreased. However, training accuracy remained nearly the same."
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.13.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
